Publications

• Immunoglobulin G N-glycan markers of accelerated biological aging during chronic HIV infection.
  Nature communications. 2024 Apr 10;15(1):3035; Authors: Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, Zhang J, Azevedo JLLC, Li SH, Shalygin S, Azadi P, Hanna DB, Ofotokun I, Lazar J, Fischl MA, Haberlen S, Macatangay B, Adimora AA, Jamieson BD, Rinaldo C, Merenstein D, Roan NR, Kutsch O, Gange S, Wolinsky SM, Witt MD, Post WS, Kossenkov A, Landay AL, Frank I, Tien PC, Gross R, Brown TT, Abdel-Mohsen M

• Polytopic fractional delivery of an HIV vaccine alters cellular responses and results in increased epitope breadth in a phase 1 randomized trial.
  EBioMedicine. 2024 Feb;100:104987 Epub 2024 Feb 1; Authors: Miner MD, deCamp A, Grunenberg N, De Rosa SC, Fiore-Gartland A, Bar K, Spearman P, Allen M, Yu PC, Manso B, Frahm N, Kalams S, Baden L, Keefer MC, Scott HM, Novak R, Van Tieu H, Tomaras GD, Kublin JG, McElrath MJ, Corey L, Frank I, HVTN 085 Study Team

• Plasma Glycomic Markers of Accelerated Biological Aging During Chronic HIV Infection.
  bioRxiv : the preprint server for biology. 2023 Dec 31; Authors: Giron LB, Liu Q, Adeniji OS, Yin X, Kannan T, Ding J, Lu DY, Langan S, Zhang J, Azevedo JLLC, Li SH, Shalygin S, Azadi P, Hanna DB, Ofotokun I, Lazar J, Fischl MA, Haberlen S, Macatangay B, Adimora AA, Jamieson BD, Rinaldo C, Merenstein D, Roan NR, Kutsch O, Gange S, Wolinsky S, Witt M, Post WS, Kossenkov A, Landay A, Frank I, Tien PC, Gross R, Brown TT, Abdel-Mohsen M

• Protein dose-sparing effect of AS01B adjuvant in a randomized preventive HIV vaccine trial of ALVAC-HIV (vCP2438) and adjuvanted bivalent subtype C gp120.
  The Journal of infectious diseases. 2023 Oct 5; Authors: Chirenje ZM, Laher F, Dintwe O, Muyoyeta M, deCamp AC, He Z, Grunenberg N, Laher Omar F, Seaton KE, Polakowski L, Woodward Davis AS, Maganga L, Baden LR, Mayer K, Kalams S, Keefer M, Edupuganti S, Rodriguez B, Frank I, Scott H, Stranix-Chibanda L, Gurunathan S, Koutsoukos M, Van Der Meeren O, DiazGranados CA, Paez C, Andersen-Nissen E, Kublin J, Corey L, Ferrari G, Tomaras G, McElrath MJ, HVTN120 study team

• Relationship between Veterans Crisis Line risk rating and subsequent suicidal self-directed violence among veteran callers: A gender comparison.
  Suicide & life-threatening behavior. 2023 Oct;53(5):739-747 Epub 2023 Aug 1; Authors: Chhatre S, Hoffmire CA, Bellamy SL, Agha AZ, Dichter ME

• Does food use disorder exist? Item response theory analyses of a food use disorder adapted from the DSM-5 substance use disorder criteria in a treatment seeking clinical sample.
  Drug and alcohol dependence. 2023 Oct 1;251:110937 Epub 2023 Aug 23; Authors: Chapron SA, Kervran C, Da Rosa M, Fournet L, Shmulewitz D, Hasin D, Denis C, Collombat J, Monsaingeon M, Fatseas M, Gatta-Cherifi B, Serre F, Auriacombe M

• A Randomized Controlled Pilot Study of Just4Us, a Counseling and Navigation Intervention to Promote Oral HIV Prophylaxis Uptake Among PrEP-Eligible Cisgender Women.
  AIDS and behavior. 2023 Sep;27(9):2944-2958 Epub 2023 Mar 4; Authors: Teitelman AM, Tieu HV, Chittamuru D, Shaw PA, Nandi V, Davis A, Lipsky RK, Darlington CK, Fiore D, Koblin BA

• Association between hospital competition and quality of prostate cancer care.
  BMC health services research. 2023 Aug 5;23(1):828; Authors: Jayadevappa R, Malkowicz SB, Vapiwala N, Guzzo TJ, Chhatre S

• "It's Better If I Die Because Even in the Hospital, There is a Stigma, People Still Gossip": Gossip as a Culturally Shaped Labeling Process and Its Implications for HIV-Related Stigma in Botswana.
  AIDS and behavior. 2023 Aug;27(8):2535-2547 Epub 2023 Jan 17; Authors: Poku OB, Eschliman EL, Entaile P, Rampa S, Mehta H, Tal D, Silvert L, Li T, Becker TD, Govindasamy D, Stockton MA, Adedimeji A, Ho-Foster A, Blank MB, Dangerfield DT 2nd, Yang LH, Murray SM

• Lung Cancer Screening Decision Aid Designed for a Primary Care Setting: A Randomized Clinical Trial.
  JAMA network open. 2023 Aug 1;6(8):e2330452; Authors: Schapira MM, Hubbard RA, Whittle J, Vachani A, Kaminstein D, Chhatre S, Rodriguez KL, Bastian LA, Kravetz JD, Asan O, Prigge JM, Meline J, Schrand S, Ibarra JV, Dye DA, Rieder JB, Frempong JO, Fraenkel L

• Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition.
  EBioMedicine. 2023 Jul;93:104590 Epub 2023 Jun 8; Authors: Seaton KE, Huang Y, Karuna S, Heptinstall JR, Brackett C, Chiong K, Zhang L, Yates NL, Sampson M, Rudnicki E, Juraska M, deCamp AC, Edlefsen PT, Mullins JI, Williamson C, Rossenkhan R, Giorgi EE, Kenny A, Angier H, Randhawa A, Weiner JA, Rojas M, Sarzotti-Kelsoe M, Zhang L, Sawant S, Ackerman ME, McDermott AB, Mascola JR, Hural J, McElrath MJ, Andrew P, Hidalgo JA, Clark J, Laher F, Orrell C, Frank I, Gonzales P, Edupuganti S, Mgodi N, Corey L, Morris L, Montefiori D, Cohen MS, Gilbert PB, Tomaras GD

• Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial.
  BMC infectious diseases. 2023 May 11;23(1):319; Authors: Dumchev K, Guo X, Ha TV, Djoerban Z, Zeziulin O, Go VF, Sarasvita R, Metzger DS, Latkin CA, Rose SM, Piwowar-Manning E, Richardson P, Hanscom B, Lancaster KE, Miller WC, Hoffman IF

• Continuity of care and advanced prostate cancer.
  Cancer medicine. 2023 May;12(10):11795-11805 Epub 2023 Mar 23; Authors: Jayadevappa R, Guzzo T, Vapiwala N, Malkowicz SB, Gallo JJ, Chhatre S

• Impact of drug consumption rooms on non-fatal overdoses, abscesses and emergency department visits in people who inject drugs in France: results from the COSINUS cohort.
  International journal of epidemiology. 2023 Apr 19;52(2):562-576; Authors: Roux P, Jauffret-Roustide M, Donadille C, Briand Madrid L, Denis C, Célérier I, Chauvin C, Hamelin N, Maradan G, Carrieri MP, Protopopescu C, Lalanne L, Auriacombe M, COSINUS Study Group

• Cellular and humoral responses to an HIV DNA prime by electroporation boosted with recombinant vesicular stomatitis virus expressing HIV subtype C Env in a randomized controlled clinical trial.
  Vaccine. 2023 Apr 17;41(16):2696-2706 Epub 2023 Mar 17; Authors: Wilson GJ, Rodriguez B, Li SS, Allen M, Frank I, Rudnicki E, Trahey M, Kalams S, Hannaman D, Clarke DK, Xu R, Egan M, Eldridge J, Pensiero M, Latham T, Ferrari G, Montefiori DC, Tomaras GD, De Rosa SC, Jacobson JM, Miner MD, Elizaga M, HIV Vaccine Trials Network 112 Protocol Team

• Trajectory of Depression among Prostate Cancer Patients: A Secondary Analysis of a Randomized Controlled Trial.
  Cancers. 2023 Apr 2;15(7); Authors: Chhatre S, Gallo JJ, Guzzo T, Morales KH, Newman DK, Vapiwala N, Van Arsdalen K, Wein AJ, Malkowicz SB, Jayadevappa R

• HIV post-treatment controllers have distinct immunological and virological features.
  Proceedings of the National Academy of Sciences of the United States of America. 2023 Mar 14;120(11):e2218960120 Epub 2023 Mar 6; Authors: Etemad B, Sun X, Li Y, Melberg M, Moisi D, Gottlieb R, Ahmed H, Aga E, Bosch RJ, Acosta EP, Yuki Y, Martin MP, Carrington M, Gandhi RT, Jacobson JM, Volberding P, Connick E, Mitsuyasu R, Frank I, Saag M, Eron JJ, Skiest D, Margolis DM, Havlir D, Schooley RT, Lederman MM, Yu XG, Li JZ

• Racial Disparity in Outcomes Among Prostate Cancer Patients in the Post-Affordable Care Act Period.
  Urology practice. 2023 Mar;10(2):123-129 Epub 2023 Jan 23; Authors: Chhatre S, Malkowicz SB, Gallo JJ, Jayadevappa R

• Gender Differences in Connecting Veterans to Care Through the Veterans Crisis Line: A Mixed Methods Evaluation of Referrals to Suicide Prevention Coordinators.
  Medical care. 2023 Jan 1;61(1):50-53 Epub 2022 Nov 21; Authors: Krishnamurti LS, Agha A, Denneson LM, Montgomery AE, Chhatre S, Dichter ME

• Toward Meaningful Cultural Adaptation Across Implementation Stages: Lessons Learned From a Culturally Based HIV Stigma Intervention in Gaborone, Botswana.
  Global health, science and practice. 2022 Dec 21;10(6); Authors: Poku OB, Eschliman EL, Wang RY, Rampa S, Mehta H, Entaile P, Li T, Jackson VW, Ho-Foster A, Blank MB, Yang LH

• Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305).
  AIDS and behavior. 2022 Dec;26(12):4107-4114 Epub 2022 Jun 10; Authors: Mayer KH, Yuhas K, Amico KR, Wilkin T, Landovitz RJ, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, Cottle LM, Marcus C, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu AY, Frank I, Ho K, Santana J, Stekler JD, Chen YQ, McCauley M, Gulick RM, HPTN 069/ACTG 5305 Study Team

• Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy.
  Cell reports. Medicine. 2022 Nov 15;3(11):100811 Epub 2022 Oct 24; Authors: Herman JD, Wang C, Burke JS, Zur Y, Compere H, Kang J, Macvicar R, Taylor S, Shin S, Frank I, Siegel D, Tebas P, Choi GH, Shaw PA, Yoon H, Pirofski LA, Julg BD, Bar KJ, Lauffenburger D, Alter G

• Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19.
  JCI insight. 2022 Nov 8;7(21); Authors: Schuster DJ, Karuna S, Brackett C, Wesley M, Li SS, Eisel N, Tenney D, Hilliard S, Yates NL, Heptinstall JR, Williams LD, Shen X, Rolfe R, Cabello R, Zhang L, Sawant S, Hu J, Randhawa AK, Hyrien O, Hural JA, Corey L, Frank I, Tomaras GD, Seaton KE, HVTN 405/HPTN 1901 Study Team

• Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trials.
  JAMIA open. 2022 Dec;5(4):ooac091 Epub 2022 Nov 8; Authors: Yuh T, Srivastava T, Fiore D, Schmidt H, Frank I, Metzger D, Momplaisir F

• SARS-CoV-2 infections elicit higher levels of original antigenic sin antibodies compared with SARS-CoV-2 mRNA vaccinations.
  Cell reports. 2022 Oct 18;41(3):111496; Authors: Anderson EM, Li SH, Awofolaju M, Eilola T, Goodwin E, Bolton MJ, Gouma S, Manzoni TB, Hicks P, Goel RR, Painter MM, Apostolidis SA, Mathew D, Dunbar D, Fiore D, Brock A, Weaver J, Millar JS, DerOhannessian S, UPenn COVID Processing Unit, Greenplate AR, Frank I, Rader DJ, Wherry EJ, Bates P, Hensley SE

• Altered adipose tissue macrophage populations in people with HIV on integrase inhibitor-containing antiretroviral therapy.
  AIDS (London, England). 2022 Sep 1;36(11):1493-1500 Epub 2022 Jul 8; Authors: Vakili S, Paneru B, Guerrier CM, Miller J, Baumrin E, Forrestel A, Lynn K, Frank I, Lo Re V 3rd, Collman RG, Hill DA

• Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress.
  Research and practice in thrombosis and haemostasis. 2022 Jul;6(5):e12747 Epub 2022 Jul 6; Authors: Ariëns RA, Hunt BJ, Agbani EO, Ahnström J, Ahrends R, Alikhan R, Assinger A, Bagoly Z, Balduini A, Barbon E, Barrett CD, Batty P, Carneiro JDA, Chan WS, de Maat M, de Wit K, Denis C, Ellis MH, Eslick R, Fu H, Hayward CPM, Ho-Tin-Noé B, Klok FA, Kumar R, Leiderman K, Litvinov RI, Mackman N, McQuilten Z, Neal MD, Parker WAE, Preston RJS, Rayes J, Rezaie AR, Roberts LN, Rocca B, Shapiro S, Siegal DM, Sousa LP, Suzuki-Inoue K, Zafar T, Zhou J

• Variation in call volume to the Veterans Crisis Line by women and men veterans prior to and following onset of the COVID-19 pandemic.
  Journal of psychiatric research. 2022 Jul;151:561-563 Epub 2022 May 23; Authors: Dichter ME, Chhatre S, Hoffmire C, Bellamy S, Montgomery AE, McCoy I

• A pilot pragmatic trial of a "what matters most"-based intervention targeting intersectional stigma related to being pregnant and living with HIV in Botswana.
  AIDS research and therapy. 2022 Jun 23;19(1):26; Authors: Yang LH, Eschliman EL, Mehta H, Misra S, Poku OB, Entaile P, Becker TD, Melese T, Brooks MJ, Eisenberg M, Stockton MA, Choe K, Tal D, Li T, Go VF, Link BG, Rampa S, Jackson VW, Manyeagae GD, Arscott-Mills T, Goodman M, Opondo PR, Ho-Foster AR, Blank MB

• A phase I trial of cyclosporine for hospitalized patients with COVID-19.
  JCI insight. 2022 Jun 8;7(11); Authors: Blumberg EA, Noll JH, Tebas P, Fraietta JA, Frank I, Marshall A, Chew A, Veloso EA, Carulli A, Rogal W, Gaymon AL, Schmidt AH, Barnette T, Jurek R, Martins R, Hudson BM, Chavda K, Bailey CM, Church SE, Noorchashm H, Hwang WT, June CH, Hexner EO

• A Veteran-Centric Web-Based Decision Aid for Lung Cancer Screening: Usability Analysis.
  JMIR formative research. 2022 Apr 8;6(4):e29039; Authors: Schapira MM, Chhatre S, Prigge JM, Meline J, Kaminstein D, Rodriguez KL, Fraenkel L, Kravetz JD, Whittle J, Bastian LA, Vachani A, Akers S, Schrand S, Ibarra JV, Asan O

• Development of mRNA manufacturing for vaccines and therapeutics: mRNA platform requirements and development of a scalable production process to support early phase clinical trials.
  Translational research : the journal of laboratory and clinical medicine. 2022 Apr;242:38-55 Epub 2021 Dec 4; Authors: Whitley J, Zwolinski C, Denis C, Maughan M, Hayles L, Clarke D, Snare M, Liao H, Chiou S, Marmura T, Zoeller H, Hudson B, Peart J, Johnson M, Karlsson A, Wang Y, Nagle C, Harris C, Tonkin D, Fraser S, Capiz L, Zeno CL, Meli Y, Martik D, Ozaki DA, Caparoni A, Dickens JE, Weissman D, Saunders KO, Haynes BF, Sempowski GD, Denny TN, Johnson MR

• Initial analysis of viral dynamics and circulating viral variants during the mRNA-1273 Phase 3 COVE trial.
  Nature medicine. 2022 Apr;28(4):823-830 Epub 2022 Feb 10; Authors: Pajon R, Paila YD, Girard B, Dixon G, Kacena K, Baden LR, El Sahly HM, Essink B, Mullane KM, Frank I, Denhan D, Kerwin E, Zhao X, Ding B, Deng W, Tomassini JE, Zhou H, Leav B, Schödel F, COVE Trial Consortium

• Photodynamic therapy for stage I and II non-small cell lung cancer: A SEER-Medicare analysis 2000-2016.
  Medicine. 2022 Mar 18;101(11); Authors: Chhatre S, Murgu S, Vachani A, Jayadevappa R

• Signaling Through FcγRIIA and the C5a-C5aR Pathway Mediate Platelet Hyperactivation in COVID-19.
  Frontiers in immunology. 2022;13:834988 Epub 2022 Mar 3; Authors: Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles JR, Wu JE, Chen Z, Huang YJ, Belman J, Pattekar A, Manne S, Kuthuru O, Dougherty J, Weiderhold B, Weisman AR, Ittner CAG, Gouma S, Dunbar D, Frank I, Huang AC, Vella LA, UPenn COVID Processing Unit, Reilly JP, Hensley SE, Rauova L, Zhao L, Meyer NJ, Poncz M, Abrams CS, Wherry EJ

• The Mid-Atlantic Centers for AIDS Research Consortium: Promoting HIV Science Through Regional Collaboration.
  AIDS research and human retroviruses. 2022 Mar;38(3):181-187 Epub 2021 Sep 24; Authors: Greenberg AE, Celentano DD, Metzger DS, Magnus M, Blank MB, Davis W, Brooks D, Dominque T, Page KR, Limaye RJ, Collman RG, Chaisson RE, Zea MC, Beyrer C

• "I Think That I Have a Good Understanding of How to Protect Myself": A Qualitative Study About HIV Risk Perceptions Among Men and Gender Diverse Individuals Who Have Sex With Men.
  AIDS education and prevention : official publication of the International Society for AIDS Education. 2022 Feb;34(1):82-S5; Authors: Resnick D, Schapira MM, Andrews ME, Essoka-Lasenberry A, Davis-Vogel A, Bauermeister JA, Wood SM

• A retrospective study of HIV pre-exposure prophylaxis counselling among non-Hispanic Black youth diagnosed with bacterial sexually transmitted infections in the United States, 2014-2019.
  Journal of the International AIDS Society. 2022 Feb;25(2):e25867; Authors: Watson DL, Shaw PA, Petsis DT, Pickel J, Bauermeister JA, Frank I, Wood SM, Gross R

• Theory-Driven, Multi-Stage Process to Develop a Culturally-Informed Anti-Stigma Intervention for Pregnant Women Living with HIV in Botswana.
  International journal of MCH and AIDS. 2022;11(2):e569 Epub 2022 Oct 25; Authors: Poku OB, Becker TD, Rampa S, Misra S, Ho-Foster AR, Entaile P, Tay C, Choe K, Arscott-Mills T, Blank MB, Opondo PR, Yang LH

• Gender differences in veterans' use of the Veterans Crisis Line (VCL): Findings from VCL call data.
  General hospital psychiatry. 2022 Jan-Feb;74:65-70 Epub 2021 Dec 15; Authors: Dichter ME, Krishnamurti LS, Chhatre S, Hoffmire CA, Monteith LL, Bellamy SL, Iverson KM, Montgomery AE, Agha A, McCoy I

• A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia.
  The Journal of clinical investigation. 2021 Dec 15;131(24); Authors: Bar KJ, Shaw PA, Choi GH, Aqui N, Fesnak A, Yang JB, Soto-Calderon H, Grajales L, Starr J, Andronov M, Mastellone M, Amonu C, Feret G, DeMarshall M, Buchanan M, Caturla M, Gordon J, Wanicur A, Monroy MA, Mampe F, Lindemuth E, Gouma S, Mullin AM, Barilla H, Pronina A, Irwin L, Thomas R, Eichinger RA, Demuth F, Luning Prak ET, Pascual JL, Short WR, Elovitz MA, Baron J, Meyer NJ, Degnan KO, Frank I, Hensley SE, Siegel DL, Tebas P

• Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
  PLoS medicine. 2021 Dec;18(12):e1003868 Epub 2021 Dec 6; Authors: Karuna S, Li SS, Grant S, Walsh SR, Frank I, Casapia M, Trahey M, Hyrien O, Fisher L, Miner MD, Randhawa AK, Polakowski L, Kublin JG, Corey L, Montefiori D, HVTN 405/HPTN 1901 Study Team

• mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
  Science (New York, N.Y.). 2021 Dec 3;374(6572):abm0829; Authors: Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Baxter AE, Oldridge DA, Giles JR, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Drapeau EM, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, UPenn COVID Processing Unit‡, Frank I, Betts MR, Vella LA, Grifoni A, Weiskopf D, Sette A, Hensley SE, Davenport MP, Bates P, Luning Prak ET, Greenplate AR, Wherry EJ

• Awareness of HIV Preexposure Prophylaxis Among People at Risk for HIV: Results From the 2017-2019 National Survey of Family Growth.
  Sexually transmitted diseases. 2021 Dec 1;48(12):967-972; Authors: Keddem S, Dichter ME, Hamilton AB, Chhatre S, Sonalkar S

• Continuity of care in acute survivorship phase, and short and long-term outcomes in prostate cancer patients.
  The Prostate. 2021 Dec;81(16):1310-1319 Epub 2021 Sep 13; Authors: Chhatre S, Malkowicz SB, Jayadevappa R

• Adapting the design of a Web-based decision support clinical trial during the COVID-19 pandemic.
  Trials. 2021 Oct 23;22(1):734; Authors: Meline J, Prigge JM, Dye D, Rieder J, Asan O, Chhatre S, Fraenkel L, Kravetz JD, Rodriguez KL, Whittle J, Kaminstein D, Schapira MM

• Effects of a Health Promotion Intervention on Physical Activity in African American Men Living with HIV: Randomized Controlled Trial.
  AIDS patient care and STDs. 2021 Oct;35(10):377-384 Epub 2021 Sep 22; Authors: Jemmott JB 3rd, Jemmott LS, Zhang J, Icard LD, Kelly TA, Frank I, Bellamy SL

• Long-term depression incidence and associated mortality among African American and White prostate cancer survivors.
  Cancer. 2021 Sep 15;127(18):3476-3485 Epub 2021 Jun 1; Authors: Parikh RB, Gallo JJ, Wong YN, Robinson KW, Cashy JP, Narayan V, Jayadevappa R, Chhatre S

• Safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine formulations in healthy adults: interim results of a randomised, placebo-controlled, phase 1-2, dose-ranging study.
  The Lancet. Infectious diseases. 2021 Sep;21(9):1257-1270 Epub 2021 Apr 19; Authors: Goepfert PA, Fu B, Chabanon AL, Bonaparte MI, Davis MG, Essink BJ, Frank I, Haney O, Janosczyk H, Keefer MC, Koutsoukos M, Kimmel MA, Masotti R, Savarino SJ, Schuerman L, Schwartz H, Sher LD, Smith J, Tavares-Da-Silva F, Gurunathan S, DiazGranados CA, de Bruyn G

• Health care worker seromonitoring reveals complex relationships between common coronavirus antibodies and COVID-19 symptom duration.
  JCI insight. 2021 Aug 23;6(16); Authors: Gouma S, Weirick ME, Bolton MJ, Arevalo CP, Goodwin EC, Anderson EM, McAllister CM, Christensen SR, Dunbar D, Fiore D, Brock A, Weaver J, Millar J, DerOhannessian S, Unit TUCP, Frank I, Rader DJ, Wherry EJ, Hensley SE

• mRNA Vaccination Induces Durable Immune Memory to SARS-CoV-2 with Continued Evolution to Variants of Concern.
  bioRxiv : the preprint server for biology. 2021 Aug 23; Authors: Goel RR, Painter MM, Apostolidis SA, Mathew D, Meng W, Rosenfeld AM, Lundgreen KA, Reynaldi A, Khoury DS, Pattekar A, Gouma S, Kuri-Cervantes L, Hicks P, Dysinger S, Hicks A, Sharma H, Herring S, Korte S, Baxter AE, Oldridge DA, Giles JR, Weirick ME, McAllister CM, Awofolaju M, Tanenbaum N, Drapeau EM, Dougherty J, Long S, D'Andrea K, Hamilton JT, McLaughlin M, Williams JC, Adamski S, Kuthuru O, UPenn COVID Processing Unit, Frank I, Betts MR, Vella LA, Grifoni A, Weiskopf D, Sette A, Hensley SE, Davenport MP, Bates P, Luning Prak ET, Greenplate AR, Wherry EJ

• Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challenge.
  The Journal of clinical investigation. 2021 Aug 16;131(16); Authors: Astronomo RD, Lemos MP, Narpala SR, Czartoski J, Fleming LB, Seaton KE, Prabhakaran M, Huang Y, Lu Y, Westerberg K, Zhang L, Gross MK, Hural J, Tieu HV, Baden LR, Hammer S, Frank I, Ochsenbauer C, Grunenberg N, Ledgerwood JE, Mayer K, Tomaras G, McDermott AB, McElrath MJ

• Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.
  The New England journal of medicine. 2021 Aug 12;385(7):595-608; Authors: Landovitz RJ, Donnell D, Clement ME, Hanscom B, Cottle L, Coelho L, Cabello R, Chariyalertsak S, Dunne EF, Frank I, Gallardo-Cartagena JA, Gaur AH, Gonzales P, Tran HV, Hinojosa JC, Kallas EG, Kelley CF, Losso MH, Madruga JV, Middelkoop K, Phanuphak N, Santos B, Sued O, Valencia Huamaní J, Overton ET, Swaminathan S, Del Rio C, Gulick RM, Richardson P, Sullivan P, Piwowar-Manning E, Marzinke M, Hendrix C, Li M, Wang Z, Marrazzo J, Daar E, Asmelash A, Brown TT, Anderson P, Eshleman SH, Bryan M, Blanchette C, Lucas J, Psaros C, Safren S, Sugarman J, Scott H, Eron JJ, Fields SD, Sista ND, Gomez-Feliciano K, Jennings A, Kofron RM, Holtz TH, Shin K, Rooney JF, Smith KY, Spreen W, Margolis D, Rinehart A, Adeyeye A, Cohen MS, McCauley M, Grinsztejn B, HPTN 083 Study Team

• Racial/Ethnic Differences in COVID-19 Vaccine Hesitancy Among Health Care Workers in 2 Large Academic Hospitals.
  JAMA network open. 2021 Aug 2;4(8):e2121931; Authors: Momplaisir FM, Kuter BJ, Ghadimi F, Browne S, Nkwihoreze H, Feemster KA, Frank I, Faig W, Shen AK, Offit PA, Green-McKenzie J

• Higher colorectal tissue HIV infectivity in cisgender women compared with MSM before and during oral preexposure prophylaxis.
  AIDS (London, England). 2021 Aug 1;35(10):1585-1595; Authors: Sekabira R, McGowan I, Yuhas K, Brand RM, Marzinke MA, Manabe YC, Frank I, Eron J, Landovitz RJ, Anton P, Cranston RD, Anderson P, Mayer KH, Amico KR, Wilkin TJ, Chege W, Kekitiinwa AR, McCauley M, Gulick RM, Hendrix CW

• Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH.
  European journal of immunology. 2021 Aug;51(8):2051-2061 Epub 2021 Jun 19; Authors: Tomescu C, Kroll K, Colon K, Papasavvas E, Frank I, Tebas P, Mounzer K, Reeves RK, Montaner LJ

• Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities: A Randomized Clinical Trial.
  JAMA. 2021 Jul 6;326(1):46-55; Authors: Cohen MS, Nirula A, Mulligan MJ, Novak RM, Marovich M, Yen C, Stemer A, Mayer SM, Wohl D, Brengle B, Montague BT, Frank I, McCulloh RJ, Fichtenbaum CJ, Lipson B, Gabra N, Ramirez JA, Thai C, Chege W, Gomez Lorenzo MM, Sista N, Farrior J, Clement ME, Brown ER, Custer KL, Van Naarden J, Adams AC, Schade AE, Dabora MC, Knorr J, Price KL, Sabo J, Tuttle JL, Klekotka P, Shen L, Skovronsky DM, BLAZE-2 Investigators

• Stigma, Structural Vulnerability, and "What Matters Most" Among Women Living With HIV in Botswana, 2017.
  American journal of public health. 2021 Jul;111(7):1309-1317 Epub 2021 Jun 10; Authors: Yang LH, Poku OB, Misra S, Mehta HT, Rampa S, Eisenberg MM, Yang LS, Dai Cao TX, Blank LI, Becker TD, Link BG, Entaile P, Opondo PR, Arscott-Mills T, Ho-Foster AR, Blank MB

• Number of opioid overdoses and depression as a predictor of suicidal thoughts.
  Drug and alcohol dependence. 2021 Jul 1;224:108728 Epub 2021 Apr 24; Authors: Brown LA, Denis CM, Leon A, Blank MB, Douglas SD, Morales KH, Crits-Christoph PF, Metzger DS, Evans DL

• HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic.
  AIDS and behavior. 2021 Jul;25(7):2230-2239 Epub 2021 Jan 15; Authors: Denis CM, Dominique T, Smith P, Fiore D, Ku YC, Culhane A, Dunbar D, Brown D, Daramay M, Voytek C, Morales KH, Blank MB, Crits-Christoph PF, Douglas SD, Spitsin S, Frank I, Colon-Rivera K, Montaner LJ, Metzger DS, Evans DL

• Identifying "What Matters Most" to Men in Botswana to Promote Resistance to HIV-Related Stigma.
  Qualitative health research. 2021 Jul;31(9):1680-1696 Epub 2021 Mar 25; Authors: Misra S, Mehta HT, Eschliman EL, Rampa S, Poku OB, Wang WQ, Ho-Foster AR, Mosepele M, Becker TD, Entaile P, Arscott-Mills T, Opondo PR, Blank MB, Yang LH

• Engaging People Who Inject Drugs Living With HIV in Antiretroviral Treatment and Medication for Opioid Use Disorder: Extended Follow-up of HIV Prevention Trials Network (HPTN) 074.
  Open forum infectious diseases. 2021 Aug;8(8):ofab281 Epub 2021 May 29; Authors: Lancaster KE, Mollan KR, Hanscom BS, Shook-Sa BE, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Go VF, Dvoriak S, Reifeis SA, Piwowar-Manning EM, Richardson P, Hudgens MG, Hamilton EL, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Nhan DT, Burns DN, Miller WC, Hoffman IF

• Signaling through FcγRIIA and the C5a-C5aR pathway mediates platelet hyperactivation in COVID-19.
  bioRxiv : the preprint server for biology. 2021 May 3; Authors: Apostolidis SA, Sarkar A, Giannini HM, Goel RR, Mathew D, Suzuki A, Baxter AE, Greenplate AR, Alanio C, Abdel-Hakeem M, Oldridge DA, Giles J, Wu JE, Chen Z, Huang YJ, Pattekar A, Manne S, Kuthuru O, Dougherty J, Weiderhold B, Weisman AR, Ittner CAG, Gouma S, Dunbar D, Frank I, Huang AC, Vella LA, UPenn COVID Processing Unit, Reilly JP, Hensley SE, Rauova L, Zhao L, Meyer NJ, Poncz M, Abrams CS, Wherry EJ

• Suicide risk among persons living with HIV.
  AIDS care. 2021 May;33(5):616-622 Epub 2020 Aug 3; Authors: Brown LA, Majeed I, Mu W, McCann J, Durborow S, Chen S, Blank MB

• Do DSM-5 substance use disorder criteria differ by user care settings? An item response theory analysis approach.
  Addictive behaviors. 2021 May;116:106797 Epub 2020 Dec 25; Authors: Kervran C, Shmulewitz D, Serre F, Denis C, Roux P, Jauffret-Roustide M, Lalanne L, Hasin D, Auriacombe M

• Feasibility and Successful Enrollment in a Proof-of-Concept HIV Prevention Trial of VRC01, a Broadly Neutralizing HIV-1 Monoclonal Antibody.
  Journal of acquired immune deficiency syndromes (1999). 2021 May 1;87(1):671-679; Authors: Edupuganti S, Mgodi N, Karuna ST, Andrew P, Rudnicki E, Kochar N, deCamp A, De La Grecca R, Anderson M, Karg C, Tindale I, Greene E, Broder GB, Lucas J, Hural J, Gallardo-Cartagena JA, Gonzales P, Frank I, Sobieszczyk M, Gomez Lorenzo MM, Burns D, Anderson PL, Miner MD, Ledgerwood J, Mascola JR, Gilbert PB, Cohen MS, Corey L, HVTN 704/HPTN 085 study group

• Sero-monitoring of health care workers reveals complex relationships between common coronavirus antibodies and SARS-CoV-2 severity.
  medRxiv : the preprint server for health sciences. 2021 Apr 19; Authors: Gouma S, Weirick ME, Bolton MJ, Arevalo CP, Goodwin EC, Anderson EM, McAllister CM, Christensen SR, Dunbar D, Fiore D, Brock A, Weaver J, Millar J, DerOhannessian S, UPenn COVID Processing Unit, Frank I, Rader DJ, Wherry EJ, Hensley SE

• Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study.
  PloS one. 2021;16(4):e0250158 Epub 2021 Apr 14; Authors: Essler JL, Kane SA, Nolan P, Akaho EH, Berna AZ, DeAngelo A, Berk RA, Kaynaroglu P, Plymouth VL, Frank ID, Weiss SR, Odom John AR, Otto CM

• When Is a Harm a Harm? Discordance between Patient and Medical Experts' Evaluation of Lung Cancer Screening Attributes.
  Medical decision making : an international journal of the Society for Medical Decision Making. 2021 Apr;41(3):317-328 Epub 2021 Feb 6; Authors: Schapira MM, Rodriguez KL, Chhatre S, Fraenkel L, Bastian LA, Kravetz JD, Asan O, Akers S, Vachani A, Prigge JM, Meline J, Ibarra JV, Corn B, Kaminstein D

• Correction to: Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan.
  BMC psychiatry. 2021 Mar 23;21(1):163; Authors: Chao E, Hung CC, Lin CP, Ku YJ, Ain QU, Metzger DS, Lee TS

• Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
  The New England journal of medicine. 2021 Mar 18;384(11):1003-1014; Authors: Corey L, Gilbert PB, Juraska M, Montefiori DC, Morris L, Karuna ST, Edupuganti S, Mgodi NM, deCamp AC, Rudnicki E, Huang Y, Gonzales P, Cabello R, Orrell C, Lama JR, Laher F, Lazarus EM, Sanchez J, Frank I, Hinojosa J, Sobieszczyk ME, Marshall KE, Mukwekwerere PG, Makhema J, Baden LR, Mullins JI, Williamson C, Hural J, McElrath MJ, Bentley C, Takuva S, Gomez Lorenzo MM, Burns DN, Espy N, Randhawa AK, Kochar N, Piwowar-Manning E, Donnell DJ, Sista N, Andrew P, Kublin JG, Gray G, Ledgerwood JE, Mascola JR, Cohen MS, HVTN 704/HPTN 085 and HVTN 703/HPTN 081 Study Teams

• Prior Exposure to Intimate Partner Violence Associated With Less HIV Testing Among Young Women.
  Journal of interpersonal violence. 2021 Mar;36(5-6):NP2848-NP2867 Epub 2018 Apr 13; Authors: Washio Y, Novack Wright E, Davis-Vogel A, Chittams J, Anagnostopulos C, Kilby LM, Teitelman AM

• Under-documentation of psychiatric diagnoses among persons living with HIV in electronic medical records.
  AIDS care. 2021 Mar;33(3):311-315 Epub 2020 Jan 13; Authors: Brown LA, Mu W, McCann J, Durborow S, Blank MB

• Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs.
  AIDS (London, England). 2021 Mar 1;35(3):495-501; Authors: Zeziulin O, Mollan KR, Shook-Sa BE, Hanscom B, Lancaster KE, Dumchev K, Go VF, Chu VA, Kiriazova T, Syarif Z, Dvoryak S, Reifeis SA, Hamilton E, Sarasvita R, Rose S, Richardson P, Clarke W, Latkin CA, Metzger DS, Hoffman IF, Miller WC

• Just4Us: Development of a Counselor-Navigator and Text Message Intervention to Promote PrEP Uptake Among Cisgender Women at Elevated Risk for HIV.
  The Journal of the Association of Nurses in AIDS Care : JANAC. 2021 Mar-Apr 01;32(2):188-204; Authors: Teitelman AM, Koblin BA, Brawner BM, Davis A, Darlington C, Lipsky RK, Iwu E, Bond KT, Westover J, Fiore D, Tieu HV

• Patient preference elicitation instrument, OABCare, to facilitate shared decision-making in the care of overactive bladder.
  Neurourology and urodynamics. 2021 Mar;40(3):791-801 Epub 2021 Feb 10; Authors: Chhatre S, Newman DK, Wein AJ, Jayadevappa R

• Survival Outcomes with Photodynamic Therapy, Chemotherapy and Radiation in Patients with Stage III or Stage IV Non-Small Cell Lung Cancer.
  Cancers. 2021 Feb 15;13(4); Authors: Chhatre S, Vachani A, Allison RR, Jayadevappa R

• Psychometric Validation of a Scale to Assess Culturally-Salient Aspects of HIV Stigma Among Women Living with HIV in Botswana: Engaging "What Matters Most" to Resist Stigma.
  AIDS and behavior. 2021 Feb;25(2):459-474; Authors: Yang LH, Ho-Foster AR, Becker TD, Misra S, Rampa S, Poku OB, Entaile P, Goodman M, Blank MB

• Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care Workers: A Randomized Clinical Trial.
  JAMA internal medicine. 2021 Feb 1;181(2):195-202; Authors: Abella BS, Jolkovsky EL, Biney BT, Uspal JE, Hyman MC, Frank I, Hensley SE, Gill S, Vogl DT, Maillard I, Babushok DV, Huang AC, Nasta SD, Walsh JC, Wiletyo EP, Gimotty PA, Milone MC, Amaravadi RK, Prevention and Treatment of COVID-19 With Hydroxychloroquine (PATCH) Investigators

• Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention Trials.
  AIDS and behavior. 2021 Feb;25(2):524-531; Authors: Wood SM, Morales KH, Metzger D, Davis A, Fiore D, Petsis D, Barnett K, Koenig HC, Dowshen N, Gross R, Frank I

• Prior Sexually Transmitted Infection and Human Immunodeficiency Virus Risk Perception in a Diverse At-Risk Population of Men Who Have Sex with Men and Transgender Individuals.
  AIDS patient care and STDs. 2021 Jan;35(1):15-22; Authors: Resnick D, Morales K, Gross R, Petsis D, Fiore D, Davis-Vogel A, Metzger D, Frank I, Wood S

• Burden of Chronic Conditions Among Persons with HIV/AIDS and Psychiatric Comorbidity.
  Current HIV research. 2021;19(6):504-513; Authors: Chhatre S, Woody G, Metzger DS, Jayadevappa R

• The Identity of Human Tissue-Emigrant CD8(+) T Cells.
  Cell. 2020 Dec 23;183(7):1946-1961.e15 Epub 2020 Dec 10; Authors: Buggert M, Vella LA, Nguyen S, Wu VH, Chen Z, Sekine T, Perez-Potti A, Maldini CR, Manne S, Darko S, Ransier A, Kuri-Cervantes L, Japp AS, Brody IB, Ivarsson MA, Gorin JB, Rivera-Ballesteros O, Hertwig L, Antel JP, Johnson ME, Okoye A, Picker L, Vahedi G, Sparrelid E, Llewellyn-Lacey S, Gostick E, Sandberg JK, Björkström N, Bar-Or A, Dori Y, Naji A, Canaday DH, Laufer TM, Wells AD, Price DA, Frank I, Douek DC, Wherry EJ, Itkin MG, Betts MR

• Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1.
  Proceedings of the National Academy of Sciences of the United States of America. 2020 Dec 15;117(50):32066-32077 Epub 2020 Nov 25; Authors: Bertagnolli LN, Varriale J, Sweet S, Brockhurst J, Simonetti FR, White J, Beg S, Lynn K, Mounzer K, Frank I, Tebas P, Bar KJ, Montaner LJ, Siliciano RF, Siliciano JD

• Persons who inject drugs (PWID) retain functional NK cells, dendritic cell stimulation, and adaptive immune recall responses despite prolonged opioid use.
  Journal of leukocyte biology. 2020 Dec 2; Authors: Tomescu C, Colon K, Smith P, Taylor M, Azzoni L, Metzger DS, Montaner LJ

• 'Mothers moving towards empowerment' intervention to reduce stigma and improve treatment adherence in pregnant women living with HIV in Botswana: study protocol for a pragmatic clinical trial.
  Trials. 2020 Oct 7;21(1):832; Authors: Poku OB, Ho-Foster AR, Entaile P, Misra S, Mehta H, Rampa S, Goodman M, Arscott-Mills T, Eschliman E, Jackson V, Melese T, Becker TD, Eisenberg M, Link B, Go V, Opondo PR, Blank MB, Yang LH

• Squamous Cell Carcinoma of the Bladder Is Not Associated With High-risk HPV.
  Urology. 2020 Oct;144:158-163 Epub 2020 Jul 16; Authors: Gordetsky J, Spieker AJ, Pena MDCR, Kamanda S, Anderson MR, Cheville J, Boorjian S, Frank I, Granada CP, Comperat E, Hirsch MS, Iczkowski KA, Imblum B, Schwartz L, Giannico GA, Rais-Bahrami S

• Comparison by Race of Conservative Management for Low-Risk and Intermediate-Risk Prostate Cancers in Veterans From 2004 to 2018.
  JAMA network open. 2020 Sep 1;3(9):e2018318; Authors: Parikh RB, Robinson KW, Chhatre S, Medvedeva E, Cashy JP, Veera S, Bauml JM, Fojo T, Navathe AS, Malkowicz SB, Mamtani R, Jayadevappa R

• Sources of Information for Learning and Decision-Making in Men With Localized Prostate Cancer.
  American journal of men's health. 2020 Sep-Oct;14(5):1557988320945461; Authors: Chhatre S, Wittink MN, Gallo JJ, Jayadevappa R

• Recommendations for measuring HIV reservoir size in cure-directed clinical trials.
  Nature medicine. 2020 Sep;26(9):1339-1350 Epub 2020 Sep 7; Authors: Abdel-Mohsen M, Richman D, Siliciano RF, Nussenzweig MC, Howell BJ, Martinez-Picado J, Chomont N, Bar KJ, Yu XG, Lichterfeld M, Alcami J, Hazuda D, Bushman F, Siliciano JD, Betts MR, Spivak AM, Planelles V, Hahn BH, Smith DM, Ho YC, Buzon MJ, Gaebler C, Paiardini M, Li Q, Estes JD, Hope TJ, Kostman J, Mounzer K, Caskey M, Fox L, Frank I, Riley JL, Tebas P, Montaner LJ, BEAT-HIV Delaney Collaboratory to Cure HIV-1 infection

• Beliefs Associated with Intention to Use PrEP Among Cisgender U.S. Women at Elevated HIV Risk.
  Archives of sexual behavior. 2020 Aug;49(6):2213-2221 Epub 2020 Apr 8; Authors: Teitelman AM, Chittamuru D, Koblin BA, Davis A, Brawner BM, Fiore D, Broomes T, Ortiz G, Lucy D, Tieu HV

• Adherence among HIV-positive injection drug users undergoing methadone treatment in Taiwan.
  BMC psychiatry. 2020 Jul 2;20(1):346; Authors: Chao E, Hung CC, Lin CP, Ku YJ, Ain QU, Metzger DS, Lee TS

• Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?
  Drug and alcohol dependence. 2020 Jul 1;212:108036 Epub 2020 May 12; Authors: Kervran C, Shmulewitz D, Serre F, Stohl M, Denis C, Hasin D, Auriacombe M

• Causal Pathways Between Severe Mental Illness and Behaviors Related to HIV: Patient Perspectives.
  Community mental health journal. 2020 Feb;56(2):338-347 Epub 2019 Sep 18; Authors: Sahota PC, Cakouros BE, Russell R, Hassler M, Blank MB, Barg FK

• Association between adherence to continuous positive airway pressure treatment and cost among medicare enrollees.
  Sleep. 2020 Jan 13;43(1); Authors: Chhatre S, Chang YHA, Gooneratne NS, Kuna S, Strollo P, Jayadevappa R

• Reply to A. Vickers et al.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Dec 10;37(35):3463-3464 Epub 2019 Sep 30; Authors: Jayadevappa R, Chhatre S, Gallo JJ, Wittink MN, Morales KH, Lee DI, Guzzo T, Vapiwala N, Wong YN, Newman DK, Van Arsdalen K, Malkowicz SB, Schwartz JS, Wein AJ

• Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.
  Journal of acquired immune deficiency syndromes (1999). 2019 Dec 1;82 Suppl 2(2):S142-S147; Authors: Denis CM, Morales KH, Wu Q, Metzger DS, Cheatle MD

• The Mid-Atlantic Center for AIDS Research Consortium Scholars Program: A Multi-Institutional Approach to Mentoring the Next Generation of Underrepresented Scientists.
  Journal of acquired immune deficiency syndromes (1999). 2019 Dec 1;82 Suppl 2(2):S124-S127; Authors: Limaye RJ, Magnus M, Metzger D, Blank MB, Davis W, Celentano DD, Mid-Atlantic Center for AIDS Research Consortium

• The Social and Behavioral Sciences Research Network: Shaping a Contemporary Agenda for Research in HIV.
  Journal of acquired immune deficiency syndromes (1999). 2019 Dec 1;82 Suppl 2(2):S81-S83; Authors: Blank MB, Metzger DS, Wingood GM, DiClemente RJ

• Association between HIV infection and outcomes of care among medicare enrollees with breast cancer.
  EClinicalMedicine. 2019 Dec;17:100205 Epub 2019 Nov 26; Authors: Chhatre S, Schapira M, Metzger DS, Jayadevappa R

• DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.
  The Journal of clinical investigation. 2019 Nov 1;129(11):4769-4785; Authors: Rouphael NG, Morgan C, Li SS, Jensen R, Sanchez B, Karuna S, Swann E, Sobieszczyk ME, Frank I, Wilson GJ, Tieu HV, Maenza J, Norwood A, Kobie J, Sinangil F, Pantaleo G, Ding S, McElrath MJ, De Rosa SC, Montefiori DC, Ferrari G, Tomaras GD, Keefer MC, HVTN 105 Protocol Team and the NIAID HIV Vaccine Trials Network

• Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.
  The Journal of clinical investigation. 2019 Nov 1;129(11):4838-4849; Authors: Neidich SD, Fong Y, Li SS, Geraghty DE, Williamson BD, Young WC, Goodman D, Seaton KE, Shen X, Sawant S, Zhang L, deCamp AC, Blette BS, Shao M, Yates NL, Feely F, Pyo CW, Ferrari G, HVTN 505 Team, Frank I, Karuna ST, Swann EM, Mascola JR, Graham BS, Hammer SM, Sobieszczyk ME, Corey L, Janes HE, McElrath MJ, Gottardo R, Gilbert PB, Tomaras GD

• Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine Trial.
  Journal of virology. 2019 Nov 1;93(21) Epub 2019 Oct 15; Authors: Li SS, Gilbert PB, Carpp LN, Pyo CW, Janes H, Fong Y, Shen X, Neidich SD, Goodman D, deCamp A, Cohen KW, Ferrari G, Hammer SM, Sobieszczyk ME, Mulligan MJ, Buchbinder SP, Keefer MC, DeJesus E, Novak RM, Frank I, McElrath MJ, Tomaras GD, Geraghty DE, Peng X

• Outcomes of patients with advanced non-small cell lung cancer and airway obstruction treated with photodynamic therapy and non-photodynamic therapy ablation modalities.
  Journal of thoracic disease. 2019 Oct;11(10):4389-4399; Authors: Jayadevappa R, Chhatre S, Soukiasian HJ, Murgu S

• Mapping the Lineage Relationship between CXCR5(+) and CXCR5(-) CD4(+) T Cells in HIV-Infected Human Lymph Nodes.
  Cell reports. 2019 Sep 17;28(12):3047-3060.e7; Authors: Del Alcazar D, Wang Y, He C, Wendel BS, Del Río-Estrada PM, Lin J, Ablanedo-Terrazas Y, Malone MJ, Hernandez SM, Frank I, Naji A, Reyes-Terán G, Jiang N, Su LF

• "It's When the Trees Blossom": Explanatory Beliefs, Stigma, and Mental Illness in the Context of HIV in Botswana.
  Qualitative health research. 2019 Sep;29(11):1566-1580 Epub 2019 Feb 9; Authors: Becker TD, Ho-Foster AR, Poku OB, Marobela S, Mehta H, Cao DTX, Yang LS, Blank LI, Dipatane VI, Moeng LR, Molebatsi K, Eisenberg MM, Barg FK, Blank MB, Opondo PR, Yang LH

• Comparative effectiveness of treatments for high-risk prostate cancer patients.
  Urologic oncology. 2019 Sep;37(9):574.e11-574.e18 Epub 2019 Jul 5; Authors: Jayadevappa R, Lee DI, Chhatre S, Guzzo TJ, Malkowicz SB

• Association Between Androgen Deprivation Therapy Use and Diagnosis of Dementia in Men With Prostate Cancer.
  JAMA network open. 2019 Jul 3;2(7):e196562; Authors: Jayadevappa R, Chhatre S, Malkowicz SB, Parikh RB, Guzzo T, Wein AJ

• Placebo-controlled randomized clinical trial testing the efficacy and safety of varenicline for smokers with HIV.
  Drug and alcohol dependence. 2019 Jul 1;200:26-33 Epub 2019 May 7; Authors: Ashare RL, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Collman RG, Wileyto EP, Schnoll R

• Patient-Centered Preference Assessment to Improve Satisfaction With Care Among Patients With Localized Prostate Cancer: A Randomized Controlled Trial.
  Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Apr 20;37(12):964-973 Epub 2019 Mar 12; Authors: Jayadevappa R, Chhatre S, Gallo JJ, Wittink M, Morales KH, Lee DI, Guzzo TJ, Vapiwala N, Wong YN, Newman DK, Van Arsdalen K, Malkowicz SB, Schwartz JS, Wein AJ

• Impact of drug consumption rooms on risk practices and access to care in people who inject drugs in France: the COSINUS prospective cohort study protocol.
  BMJ open. 2019 Feb 21;9(2):e023683; Authors: Auriacombe M, Roux P, Briand Madrid L, Kirchherr S, Kervran C, Chauvin C, Gutowski M, Denis C, Carrieri MP, Lalanne L, Jauffret-Roustide M, Cosinus study group.

• Brief Report: Rate of Nicotine Metabolism and Tobacco Use Among Persons With HIV: Implications for Treatment and Research.
  Journal of acquired immune deficiency syndromes (1999). 2019 Feb 1;80(2):e36-e40; Authors: Schnoll RA, Thompson M, Serrano K, Leone F, Metzger D, Frank I, Gross R, Mounzer K, Tyndale RF, Weisbrot J, Meline M, Collman RG, Ashare RL

• S100A14 Is Increased in Activated NK Cells and Plasma of HIV-Exposed Seronegative People Who Inject Drugs and Promotes Monocyte-NK Crosstalk.
  Journal of acquired immune deficiency syndromes (1999). 2019 Feb 1;80(2):234-241; Authors: Colón K, Speicher DW, Smith P, Taylor M, Metzger DS, Montaner LJ, Tomescu C

• Development and validation of a virtual agent to screen tobacco and alcohol use disorders.
  Drug and alcohol dependence. 2018 Dec 1;193:1-6 Epub 2018 Oct 6; Authors: Auriacombe M, Moriceau S, Serre F, Denis C, Micoulaud-Franchi JA, de Sevin E, Bonhomme E, Bioulac S, Fatseas M, Philip P

• Ocrelizumab reduces progression of upper extremity impairment in patients with primary progressive multiple sclerosis: Findings from the phase III randomized ORATORIO trial.
  Multiple sclerosis (Houndmills, Basingstoke, England). 2018 Dec;24(14):1862-1870 Epub 2018 Nov 12; Authors: Fox EJ, Markowitz C, Applebee A, Montalban X, Wolinsky JS, Belachew S, Fiore D, Pei J, Musch B, Giovannoni G

• Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders.
  Community mental health journal. 2018 Nov;54(8):1146-1153 Epub 2018 May 11; Authors: Coviello DM, Lovato R, Apostol K, Eisenberg MM, Metzger DS, Szucs-Reed R, Kiryankova-Dalseth N, Kelly D, Jackson A, Plano M, Blank MB

• Association between overactive bladder treatment and falls among older adults.
  Neurourology and urodynamics. 2018 Nov;37(8):2688-2694 Epub 2018 May 28; Authors: Jayadevappa R, Chhatre S, Newman DK, Schwartz JS, Wein AJ

• Safety and tolerability of HIV-1 multiantigen pDNA vaccine given with IL-12 plasmid DNA via electroporation, boosted with a recombinant vesicular stomatitis virus HIV Gag vaccine in healthy volunteers in a randomized, controlled clinical trial.
  PloS one. 2018;13(9):e0202753 Epub 2018 Sep 20; Authors: Elizaga ML, Li SS, Kochar NK, Wilson GJ, Allen MA, Tieu HVN, Frank I, Sobieszczyk ME, Cohen KW, Sanchez B, Latham TE, Clarke DK, Egan MA, Eldridge JH, Hannaman D, Xu R, Ota-Setlik A, McElrath MJ, Hay CM, NIAID HIV Vaccine Trials Network (HVTN) 087 Study Team

• A scalable, integrated intervention to engage people who inject drugs in HIV care and medication-assisted treatment (HPTN 074): a randomised, controlled phase 3 feasibility and efficacy study.
  Lancet (London, England). 2018 Sep 1;392(10149):747-759; Authors: Miller WC, Hoffman IF, Hanscom BS, Ha TV, Dumchev K, Djoerban Z, Rose SM, Latkin CA, Metzger DS, Lancaster KE, Go VF, Dvoriak S, Mollan KR, Reifeis SA, Piwowar-Manning EM, Richardson P, Hudgens MG, Hamilton EL, Sugarman J, Eshleman SH, Susami H, Chu VA, Djauzi S, Kiriazova T, Bui DD, Strathdee SA, Burns DN

• Predictors of craving and substance use among patients with alcohol, tobacco, cannabis or opiate addictions: Commonalities and specificities across substances.
  Addictive behaviors. 2018 Aug;83:123-129 Epub 2018 Feb 2; Authors: Serre F, Fatseas M, Denis C, Swendsen J, Auriacombe M

• Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial.
  HIV clinical trials. 2018 Aug;19(4):129-138 Epub 2018 Nov 16; Authors: Murray MI, Markowitz M, Frank I, Grant RM, Mayer KH, Hudson KJ, Stancil BS, Ford SL, Patel P, Rinehart AR, Spreen WR, Margolis DA

• Knowledge and attitude for overactive bladder care among women: development and measurement.
  BMC urology. 2018 Jun 5;18(1):56; Authors: Chhatre S, Newman DK, Wein AJ, Jefferson AE, Schwartz JS, Jayadevappa R

• Identification and characterization of HIV-specific resident memory CD8(+) T cells in human lymphoid tissue.
  Science immunology. 2018 Jun 1;3(24); Authors: Buggert M, Nguyen S, Salgado-Montes de Oca G, Bengsch B, Darko S, Ransier A, Roberts ER, Del Alcazar D, Brody IB, Vella LA, Beura L, Wijeyesinghe S, Herati RS, Del Rio Estrada PM, Ablanedo-Terrazas Y, Kuri-Cervantes L, Sada Japp A, Manne S, Vartanian S, Huffman A, Sandberg JK, Gostick E, Nadolski G, Silvestri G, Canaday DH, Price DA, Petrovas C, Su LF, Vahedi G, Dori Y, Frank I, Itkin MG, Wherry EJ, Deeks SG, Naji A, Reyes-Terán G, Masopust D, Douek DC, Betts MR

• HIV Prevalence Among Hospitalized Patients at the Main Psychiatric Referral Hospital in Botswana.
  AIDS and behavior. 2018 May;22(5):1503-1516; Authors: Opondo PR, Ho-Foster AR, Ayugi J, Hatitchki B, Pumar M, Bilker WB, Thase ME, Jemmott JB 3rd, Blank MB, Evans DL

• CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells.
  Science translational medicine. 2018 Apr 18;10(437); Authors: Abdel-Mohsen M, Kuri-Cervantes L, Grau-Exposito J, Spivak AM, Nell RA, Tomescu C, Vadrevu SK, Giron LB, Serra-Peinado C, Genescà M, Castellví J, Wu G, Del Rio Estrada PM, González-Navarro M, Lynn K, King CT, Vemula S, Cox K, Wan Y, Li Q, Mounzer K, Kostman J, Frank I, Paiardini M, Hazuda D, Reyes-Terán G, Richman D, Howell B, Tebas P, Martinez-Picado J, Planelles V, Buzon MJ, Betts MR, Montaner LJ

• Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis.
  Research and practice in thrombosis and haemostasis. 2018 Jul;2(3):407-428 Epub 2018 Apr 12; Authors: Bergmeier W, Antoniak S, Conway EM, Denis CV, George LA, Isermann B, Key NS, Krishnaswamy S, Lam WA, Lillicrap D, Liu J, Looney MR, López JA, Maas C, Peyvandi F, Ruf W, Sood AK, Versteeg HH, Wolberg AS, Wong PC, Wood JP, Weiler H

• Lessons for Patient Education Around Long-Acting Injectable PrEP: Findings from a Mixed-Method Study of Phase II Trial Participants.
  AIDS and behavior. 2018 Apr;22(4):1209-1216; Authors: Meyers K, Rodriguez K, Brill AL, Wu Y, La Mar M, Dunbar D, Koblin B, Margolis D, Sobieszczyk ME, Van Tieu H, Frank I, Markowitz M, Golub SA

• BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS.
  Retina (Philadelphia, Pa.). 2018 Apr;38(4):650-659; Authors: Kolomeyer AM, Murphy KM, Traband A, Frank I, Kim BJ

• Racial and ethnic disparities in substance use disorders and outcomes in elderly prostate cancer patients.
  Journal of ethnicity in substance abuse. 2018 Apr-Jun;17(2):135-149 Epub 2016 Apr 26; Authors: Chhatre S, Jayadevappa R

• Modification of the Association Between T-Cell Immune Responses and Human Immunodeficiency Virus Type 1 Infection Risk by Vaccine-Induced Antibody Responses in the HVTN 505 Trial.
  The Journal of infectious diseases. 2018 Mar 28;217(8):1280-1288; Authors: Fong Y, Shen X, Ashley VC, Deal A, Seaton KE, Yu C, Grant SP, Ferrari G, deCamp AC, Bailer RT, Koup RA, Montefiori D, Haynes BF, Sarzotti-Kelsoe M, Graham BS, Carpp LN, Hammer SM, Sobieszczyk M, Karuna S, Swann E, DeJesus E, Mulligan M, Frank I, Buchbinder S, Novak RM, McElrath MJ, Kalams S, Keefer M, Frahm NA, Janes HE, Gilbert PB, Tomaras GD

• Patient-centered recruitment and retention for a randomized controlled study.
  Trials. 2018 Mar 27;19(1):205; Authors: Chhatre S, Jefferson A, Cook R, Meeker CR, Kim JH, Hartz KM, Wong YN, Caruso A, Newman DK, Morales KH, Jayadevappa R

• Does Diagnosis Make a Difference? Estimating the Impact of an HIV Medication Adherence Intervention for Persons with Serious Mental Illness.
  AIDS and behavior. 2018 Jan;22(1):265-275; Authors: Dalseth N, Reed RS, Hennessy M, Eisenberg MM, Blank MB

• Is Tobacco Use Associated with Neurocognitive Dysfunction in Individuals with HIV?
  Journal of the International Association of Providers of AIDS Care. 2018 Jan-Dec;17:2325958218768018; Authors: Tsima B, Ratcliffe SJ, Schnoll R, Frank I, Kolson DL, Gross R

• Racial Inequities in HIV Prevalence and Composition of Risk Networks Among People Who Inject Drugs in HIV Prevention Trial Network 037.
  Journal of acquired immune deficiency syndromes (1999). 2017 Dec 1;76(4):394-401; Authors: Momplaisir F, Hussein M, Tobin-Fiore D, Smith L, Bennett D, Latkin C, Metzger DS

• Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
  PLoS medicine. 2017 Nov;14(11):e1002435 Epub 2017 Nov 14; Authors: Mayer KH, Seaton KE, Huang Y, Grunenberg N, Isaacs A, Allen M, Ledgerwood JE, Frank I, Sobieszczyk ME, Baden LR, Rodriguez B, Van Tieu H, Tomaras GD, Deal A, Goodman D, Bailer RT, Ferrari G, Jensen R, Hural J, Graham BS, Mascola JR, Corey L, Montefiori DC, HVTN 104 Protocol Team, and the NIAID HIV Vaccine Trials Network

• Patient-centred outcomes research: perspectives of patient stakeholders.
  JRSM open. 2017 Nov;8(11):2054270417738511 Epub 2017 Nov 9; Authors: Chhatre S, Gallo JJ, Wittink M, Schwartz JS, Jayadevappa R

• DNA Priming Increases Frequency of T-Cell Responses to a Vesicular Stomatitis Virus HIV Vaccine with Specific Enhancement of CD8(+) T-Cell Responses by Interleukin-12 Plasmid DNA.
  Clinical and vaccine immunology : CVI. 2017 Nov;24(11) Epub 2017 Nov 6; Authors: Li SS, Kochar NK, Elizaga M, Hay CM, Wilson GJ, Cohen KW, De Rosa SC, Xu R, Ota-Setlik A, Morris D, Finak G, Allen M, Tieu HV, Frank I, Sobieszczyk ME, Hannaman D, Gottardo R, Gilbert PB, Tomaras GD, Corey L, Clarke DK, Egan MA, Eldridge JH, McElrath MJ, Frahm N, NIAID HIV Vaccine Trials Network

• Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Women: A Phase 2 Randomized Trial.
  Annals of internal medicine. 2017 Sep 19;167(6):384-393 Epub 2017 Aug 22; Authors: Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Siegel M, Manabe YC, Frank I, Ho K, Santana J, Stekler JD, Swaminathan S, McCauley M, Hodder S, Mayer KH

• Minimal important difference to infer changes in health-related quality of life-a systematic review.
  Journal of clinical epidemiology. 2017 Sep;89:188-198 Epub 2017 Jul 1; Authors: Jayadevappa R, Cook R, Chhatre S

• How Do Social Capital and HIV/AIDS Outcomes Geographically Cluster and Which Sociocontextual Mechanisms Predict Differences Across Clusters?
  Journal of acquired immune deficiency syndromes (1999). 2017 Sep 1;76(1):13-22; Authors: Ransome Y, Dean LT, Crawford ND, Metzger DS, Blank MB, Nunn AS

• Trends in substance use admissions among older adults.
  BMC health services research. 2017 Aug 22;17(1):584; Authors: Chhatre S, Cook R, Mallik E, Jayadevappa R

• Potent Thrombolytic Effect of N-Acetylcysteine on Arterial Thrombi.
  Circulation. 2017 Aug 15;136(7):646-660 Epub 2017 May 9; Authors: Martinez de Lizarrondo S, Gakuba C, Herbig BA, Repessé Y, Ali C, Denis CV, Lenting PJ, Touzé E, Diamond SL, Vivien D, Gauberti M

• The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.
  Journal of neurovirology. 2017 Aug;23(4):550-557 Epub 2017 Apr 20; Authors: Harrison JD, Dochney JA, Blazekovic S, Leone F, Metzger D, Frank I, Gross R, Hole A, Mounzer K, Siegel S, Schnoll RA, Ashare RL

• Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial.
  The lancet. HIV. 2017 Aug;4(8):e331-e340 Epub 2017 May 22; Authors: Markowitz M, Frank I, Grant RM, Mayer KH, Elion R, Goldstein D, Fisher C, Sobieszczyk ME, Gallant JE, Van Tieu H, Weinberg W, Margolis DA, Hudson KJ, Stancil BS, Ford SL, Patel P, Gould E, Rinehart AR, Smith KY, Spreen WR

• Sociodemographic Characteristics and Health Outcomes Among Lesbian, Gay, and Bisexual U.S. Adults Using Healthy People 2020 Leading Health Indicators.
  LGBT health. 2017 Aug;4(4):283-294 Epub 2017 Jul 20; Authors: Lunn MR, Cui W, Zack MM, Thompson WW, Blank MB, Yehia BR

• Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research.
  Vaccine. 2017 Jun 14;35(27):3498-3505 Epub 2017 May 16; Authors: Buckingham L, Becher J, Voytek CD, Fiore D, Dunbar D, Davis-Vogel A, Metzger DS, Frank I

• Association Between Depression and Condom Use Differs by Sexual Behavior Group in Patients with HIV.
  AIDS and behavior. 2017 Jun;21(6):1676-1683; Authors: Brickman C, Propert KJ, Voytek C, Metzger D, Gross R

• Coercion or Caring: The Fundamental Paradox for Adherence Interventions for HIV+ People with Mental Illness.
  AIDS and behavior. 2017 Jun;21(6):1530-1539; Authors: Eisenberg MM, Hennessy M, Coviello D, Hanrahan N, Blank MB

• Comparative effectiveness of prostate cancer treatments for patient-centered outcomes: A systematic review and meta-analysis (PRISMA Compliant).
  Medicine. 2017 May;96(18):e6790; Authors: Jayadevappa R, Chhatre S, Wong YN, Wittink MN, Cook R, Morales KH, Vapiwala N, Newman DK, Guzzo T, Wein AJ, Malkowicz SB, Lee DI, Schwartz JS, Gallo JJ

• Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305).
  The Journal of infectious diseases. 2017 Jan 15;215(2):238-246; Authors: Gulick RM, Wilkin TJ, Chen YQ, Landovitz RJ, Amico KR, Young AM, Richardson P, Marzinke MA, Hendrix CW, Eshleman SH, McGowan I, Cottle LM, Andrade A, Marcus C, Klingman KL, Chege W, Rinehart AR, Rooney JF, Andrew P, Salata RA, Magnus M, Farley JE, Liu A, Frank I, Ho K, Santana J, Stekler JD, McCauley M, Mayer KH

• Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions.
  Psychiatry research. 2016 Dec 30;246:656-662 Epub 2016 Nov 1; Authors: Fatséas M, Hurmic H, Serre F, Debrabant R, Daulouède JP, Denis C, Auriacombe M

• Psychiatric Service Utilization Trends in Delaware's Public Mental Health System Following the OLMSTEAD Settlement Agreement.
  Delaware journal of public health. 2016 Dec;2(5):38-41 Epub 2016 Dec 15; Authors: Rothbard A, Zubritsky C, Chhatre S, Keogh B, Cantiello H, Holloway S

• Association between age, substance use, and outcomes in Medicare enrollees with prostate cancer.
  Journal of geriatric oncology. 2016 Nov;7(6):444-452 Epub 2016 Jul 7; Authors: Jayadevappa R, Chhatre S

• Targeting modulates audiences' brain and behavioral responses to safe sex video ads.
  Social cognitive and affective neuroscience. 2016 Oct;11(10):1650-7 Epub 2016 May 19; Authors: Wang AL, Lowen SB, Shi Z, Bissey B, Metzger DS, Langleben DD

• Diversity and Tropism of HIV-1 Rebound Virus Populations in Plasma Level After Treatment Discontinuation.
  The Journal of infectious diseases. 2016 Aug 1;214(3):403-7 Epub 2016 Apr 30; Authors: Bednar MM, Hauser BM, Zhou S, Jacobson JM, Eron JJ Jr, Frank I, Swanstrom R

• Awareness of HPV and Uptake of Vaccination in a High-Risk Population.
  Pediatrics. 2016 Aug;138(2); Authors: Fishman J, Taylor L, Frank I

• Effect of Patient Navigation With or Without Financial Incentives on Viral Suppression Among Hospitalized Patients With HIV Infection and Substance Use: A Randomized Clinical Trial.
  JAMA. 2016 Jul 12;316(2):156-70; Authors: Metsch LR, Feaster DJ, Gooden L, Matheson T, Stitzer M, Das M, Jain MK, Rodriguez AE, Armstrong WS, Lucas GM, Nijhawan AE, Drainoni ML, Herrera P, Vergara-Rodriguez P, Jacobson JM, Mugavero MJ, Sullivan M, Daar ES, McMahon DK, Ferris DC, Lindblad R, VanVeldhuisen P, Oden N, Castellón PC, Tross S, Haynes LF, Douaihy A, Sorensen JL, Metzger DS, Mandler RN, Colfax GN, del Rio C

• Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV.
  Community mental health journal. 2016 May;52(4):439-45 Epub 2014 Dec 23; Authors: Wu ES, Rothbard A, Holtgrave DR, Blank MB

• Examining the efficacy of a computer facilitated HIV prevention tool in drug court.
  Drug and alcohol dependence. 2016 May 1;162:44-50 Epub 2016 Feb 27; Authors: Festinger DS, Dugosh KL, Kurth AE, Metzger DS

• Examining multi-session brief intervention for substance use in primary care: research methods of a randomized controlled trial.
  Addiction science & clinical practice. 2016 Apr 18;11(1):8; Authors: Chambers JE, Brooks AC, Medvin R, Metzger DS, Lauby J, Carpenedo CM, Favor KE, Kirby KC

• Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2016 Mar 15;62(6):795-803 Epub 2015 Nov 26; Authors: Ravimohan S, Tamuhla N, Nfanyana K, Steenhoff AP, Letlhogile R, Frank I, MacGregor RR, Gross R, Weissman D, Bisson GP

• The F4/AS01B HIV-1 Vaccine Candidate Is Safe and Immunogenic, But Does Not Show Viral Efficacy in Antiretroviral Therapy-Naive, HIV-1-Infected Adults: A Randomized Controlled Trial.
  Medicine. 2016 Feb;95(6):e2673; Authors: Dinges W, Girard PM, Podzamczer D, Brockmeyer NH, García F, Harrer T, Lelievre JD, Frank I, Colin De Verdière N, Yeni GP, Ortega Gonzalez E, Rubio R, Clotet Sala B, DeJesus E, Pérez-Elias MJ, Launay O, Pialoux G, Slim J, Weiss L, Bouchaud O, Felizarta F, Meurer A, Raffi F, Esser S, Katlama C, Koletar SL, Mounzer K, Swindells S, Baxter JD, Schneider S, Chas J, Molina JM, Koutsoukos M, Collard A, Bourguignon P, Roman F

• Usefulness and validity of the modified Addiction Severity Index: A focus on alcohol, drugs, tobacco, and gambling.
  Substance abuse. 2016;37(1):168-75 Epub 2015 Jun 25; Authors: Denis C, Fatséas M, Beltran V, Serre F, Alexandre JM, Debrabant R, Daulouède JP, Auriacombe M

• Implementation of a Brief Treatment Counseling Toolkit in Federally Qualified Healthcare Centers: Patient and Clinician Utilization and Satisfaction.
  Journal of substance abuse treatment. 2016 Jan;60:70-80 Epub 2015 Sep 8; Authors: Brooks AC, Chambers JE, Lauby J, Byrne E, Carpenedo CM, Benishek LA, Medvin R, Metzger DS, Kirby KC

• Multicenter Comparison of Lung and Oral Microbiomes of HIV-infected and HIV-uninfected Individuals.
  American journal of respiratory and critical care medicine. 2015 Dec 1;192(11):1335-44; Authors: Beck JM, Schloss PD, Venkataraman A, Twigg H 3rd, Jablonski KA, Bushman FD, Campbell TB, Charlson ES, Collman RG, Crothers K, Curtis JL, Drews KL, Flores SC, Fontenot AP, Foulkes MA, Frank I, Ghedin E, Huang L, Lynch SV, Morris A, Palmer BE, Schmidt TM, Sodergren E, Weinstock GM, Young VB, Lung HIV Microbiome Project

• Treatment preference and patient centered prostate cancer care: Design and rationale.
  Contemporary clinical trials. 2015 Nov;45(Pt B):296-301 Epub 2015 Oct 3; Authors: Jayadevappa R, Chhatre S, Gallo JJ, Wittink M, Morales KH, Bruce Malkowicz S, Lee D, Guzzo T, Caruso A, Van Arsdalen K, Wein AJ, Sanford Schwartz J

• Assessment of contamination and misclassification biases in a randomized controlled trial of a social network peer education intervention to reduce HIV risk behaviors among drug users and risk partners in Philadelphia, PA and Chiang Mai, Thailand.
  AIDS and behavior. 2015 Oct;19(10):1818-27; Authors: Simmons N, Donnell D, Ou SS, Celentano DD, Aramrattana A, Davis-Vogel A, Metzger D, Latkin C

• Registries and syndemics: untapped potential for global health.
  The lancet. HIV. 2015 Aug;2(8):e314-5 Epub 2015 Jul 2; Authors: Blank MB, Eisenberg MM

• Inter-observer reliability of DSM-5 substance use disorders.
  Drug and alcohol dependence. 2015 Aug 1;153:229-35 Epub 2015 May 27; Authors: Denis CM, Gelernter J, Hart AB, Kranzler HR

• Understanding the Racial and Ethnic Differences in Cost and Mortality Among Advanced Stage Prostate Cancer Patients (STROBE).
  Medicine. 2015 Aug;94(32):e1353; Authors: Chhatre S, Bruce Malkowicz S, Sanford Schwartz J, Jayadevappa R

• First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Vesicular Stomatitis Virus Human Immunodeficiency Virus-1 gag Vaccine (HVTN 090).
  Open forum infectious diseases. 2015 Sep;2(3):ofv082 Epub 2015 Jun 5; Authors: Fuchs JD, Frank I, Elizaga ML, Allen M, Frahm N, Kochar N, Li S, Edupuganti S, Kalams SA, Tomaras GD, Sheets R, Pensiero M, Tremblay MA, Higgins TJ, Latham T, Egan MA, Clarke DK, Eldridge JH, HVTN 090 Study Group and the National Institutes of Allergy and Infectious Diseases HIV Vaccine Trials Network, Mulligan M, Rouphael N, Estep S, Rybczyk K, Dunbar D, Buchbinder S, Wagner T, Isbell R, Chinnell V, Bae J, Escamilla G, Tseng J, Fair R, Ramirez S, Broder G, Briesemeister L, Ferrara A

• Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial.
  Open forum infectious diseases. 2015 Apr;2(2):ofv040 Epub 2015 May 5; Authors: Overton ET, Stapleton J, Frank I, Hassler S, Goepfert PA, Barker D, Wagner E, von Krempelhuber A, Virgin G, Meyer TP, Müller J, Bädeker N, Grünert R, Young P, Rösch S, Maclennan J, Arndtz-Wiedemann N, Chaplin P

• Individual and community factors associated with geographic clusters of poor HIV care retention and poor viral suppression.
  Journal of acquired immune deficiency syndromes (1999). 2015 May 1;69 Suppl 1(0 1):S37-43; Authors: Eberhart MG, Yehia BR, Hillier A, Voytek CD, Fiore DJ, Blank M, Frank I, Metzger DS, Brady KA

• Expanding substance use treatment options for HIV prevention with buprenorphine-naloxone: HIV Prevention Trials Network 058.
  Journal of acquired immune deficiency syndromes (1999). 2015 Apr 15;68(5):554-61; Authors: Metzger DS, Donnell D, Celentano DD, Jackson JB, Shao Y, Aramrattana A, Wei L, Fu L, Ma J, Lucas GM, Chawarski M, Ruan Y, Richardson P, Shin K, Chen RY, Sugarman J, Dye BJ, Rose SM, Beauchamp G, Burns DN, HPTN 058 Protocol Team

• The CDC clearance process: an obstacle to progress in public health.
  American journal of public health. 2015 Apr;105(4):614-5 Epub 2015 Feb 25; Authors: Blank MB, Jemmott JB 3rd

• Innate activation of MDC and NK cells in high-risk HIV-1-exposed seronegative IV-drug users who share needles when compared with low-risk nonsharing IV-drug user controls.
  Journal of acquired immune deficiency syndromes (1999). 2015 Mar 1;68(3):264-73; Authors: Tomescu C, Seaton KE, Smith P, Taylor M, Tomaras GD, Metzger DS, Montaner LJ

• Medication adherence in the management of nocturia: challenges and solutions.
  Patient preference and adherence. 2015;9:77-85 Epub 2015 Jan 13; Authors: Jayadevappa R, Newman DK, Chhatre S, Wein AJ

• Authors' reply: "Risk reduction with buprenorphine-naloxone and methadone: patient's choice".
  Journal of acquired immune deficiency syndromes (1999). 2014 Dec 15;67(5):e142-3; Authors: Woody G, Bruce D, Korthuis PT, Chhatre S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Poole S, Metzger D, Ling W

• A multisite study of the prevalence of HIV with rapid testing in mental health settings.
  American journal of public health. 2014 Dec;104(12):2377-84 Epub 2014 Feb 13; Authors: Blank MB, Himelhoch SS, Balaji AB, Metzger DS, Dixon LB, Rose CE, Oraka E, Davis-Vogel A, Thompson WW, Heffelfinger JD

• HIV testing among adults with mental illness in the United States.
  AIDS patient care and STDs. 2014 Dec;28(12):628-34; Authors: Yehia BR, Cui W, Thompson WW, Zack MM, McKnight-Eily L, DiNenno E, Rose CE, Blank MB

• Substance use disorder and its effects on outcomes in men with advanced-stage prostate cancer.
  Cancer. 2014 Nov 1;120(21):3338-45 Epub 2014 Jul 9; Authors: Chhatre S, Metzger DS, Malkowicz SB, Woody G, Jayadevappa R

• Commentary on Scharkow et al. (2014): Welcomed and yet to come. Are we looking at what we are looking for?
  Addiction (Abingdon, England). 2014 Nov;109(11):1918-9; Authors: Auriacombe M, Denis C, Fatséas M

• Parent and adolescent knowledge of HPV and subsequent vaccination.
  Pediatrics. 2014 Oct;134(4):e1049-56 Epub 2014 Sep 15; Authors: Fishman J, Taylor L, Kooker P, Frank I

• Seroprotection of HIV-infected subjects after influenza A(H1N1) vaccination is directly associated with baseline frequency of naive T cells.
  The Journal of infectious diseases. 2014 Aug 15;210(4):646-50 Epub 2014 Mar 8; Authors: Ramirez LA, Daniel A, Frank I, Tebas P, Boyer JD

• HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trial.
  Journal of acquired immune deficiency syndromes (1999). 2014 Jul 1;66(3):288-93; Authors: Woody GE, Bruce D, Korthuis PT, Chhatre S, Poole S, Hillhouse M, Jacobs P, Sorensen J, Saxon AJ, Metzger D, Ling W

• Methadone maintenance for HIV positive and HIV negative patients in Kyiv: acceptability and treatment response.
  Drug and alcohol dependence. 2014 Apr 1;137:62-7 Epub 2014 Jan 30; Authors: Dvoriak S, Karachevsky A, Chhatre S, Booth R, Metzger D, Schumacher J, Chychula N, Pecoraro A, Woody G

• Incidence and risk factors for incomplete HBV DNA suppression in HIV/HBV-co-infected patients initiating tenofovir-based therapy.
  Journal of viral hepatitis. 2014 Apr;21(4):288-96 Epub 2013 Jul 30; Authors: Hafkin JS, Osborn MK, Localio AR, Amorosa VK, Kostman JR, Stern JJ, De La Torre P, Mounzer K, Frank I, Gross R, Chang KM, Lo Re V 3rd

• Increasing quality of life and reducing HIV burden: the PATH+ intervention.
  AIDS and behavior. 2014 Apr;18(4):716-25; Authors: Blank MB, Hennessy M, Eisenberg MM

• Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV.
  The New England journal of medicine. 2014 Mar 6;370(10):901-10; Authors: Tebas P, Stein D, Tang WW, Frank I, Wang SQ, Lee G, Spratt SK, Surosky RT, Giedlin MA, Nichol G, Holmes MC, Gregory PD, Ando DG, Kalos M, Collman RG, Binder-Scholl G, Plesa G, Hwang WT, Levine BL, June CH

• Improved characterization of medically relevant fungi in the human respiratory tract using next-generation sequencing.
  Genome biology. 2014;15(10):487; Authors: Bittinger K, Charlson ES, Loy E, Shirley DJ, Haas AR, Laughlin A, Yi Y, Wu GD, Lewis JD, Frank I, Cantu E, Diamond JM, Christie JD, Collman RG, Bushman FD

• Treatment considerations for HIV-infected individuals with severe mental illness.
  Current HIV/AIDS reports. 2013 Dec;10(4):371-9; Authors: Blank MB, Himelhoch S, Walkup J, Eisenberg MM

• Addiction Severity Index (ASI) summary scores: comparison of the Recent Status Scores of the ASI-6 and the Composite Scores of the ASI-5.
  Journal of substance abuse treatment. 2013 Nov-Dec;45(5):444-50 Epub 2013 Jul 23; Authors: Denis CM, Cacciola JS, Alterman AI

• Behind the cascade: analyzing spatial patterns along the HIV care continuum.
  Journal of acquired immune deficiency syndromes (1999). 2013 Nov 1;64 Suppl 1(0 1):S42-51; Authors: Eberhart MG, Yehia BR, Hillier A, Voytek CD, Blank MB, Frank I, Metzger DS, Brady KA

• Active Drug-Using Women Use Female-Initiated Barrier Methods to Reduce HIV/STI Risk: Results from a Randomized Trial.
  ISRN Addiction. 2013;2013:768258 Epub 2013 Sep 23; Authors: Gollub E, Cyrus-Cameron E, Armstrong K, Boney T, Mercer D, Fiore D, Chhatre S

• The development of a culturally relevant, theoretically driven HPV prevention intervention for urban adolescent females and their parents/guardians.
  Health promotion practice. 2013 Jul;14(4):624-36 Epub 2012 Oct 24; Authors: Brawner BM, Baker JL, Voytek CD, Leader A, Cashman RR, Silverman R, Peter N, Buchner BJ, Barnes CA, Jemmott LS, Frank I

• Patients in transition: avoiding detours on the road to HIV treatment success.
  AIDS (London, England). 2013 Jun 19;27(10):1529-33; Authors: Yehia BR, Kangovi S, Frank I

• The social and behavioral sciences research network: translational research to reduce disparities in HIV.
  Journal of acquired immune deficiency syndromes (1999). 2013 Jun 1;63 Suppl 1:S1-3; Authors: Blank MB, Metzger DS, Wingood GM, DiClemente RJ

• Tailored treatment for HIV+ persons with mental illness: the intervention cascade.
  Journal of acquired immune deficiency syndromes (1999). 2013 Jun 1;63 Suppl 1(0 1):S44-8; Authors: Blank MB, Eisenberg MM

• Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trial.
  Annals of internal medicine. 2013 Jan 1;158(1):19-26; Authors: McKittrick N, Frank I, Jacobson JM, White CJ, Kim D, Kappes R, DiGiorgio C, Kenney T, Boyer J, Tebas P

• Effects of behavioral stress reduction Transcendental Meditation intervention in persons with HIV.
  AIDS care. 2013;25(10):1291-7 Epub 2013 Feb 11; Authors: Chhatre S, Metzger DS, Frank I, Boyer J, Thompson E, Nidich S, Montaner LJ, Jayadevappa R

• The burden of depression in prostate cancer.
  Psycho-oncology. 2012 Dec;21(12):1338-45 Epub 2011 Aug 12; Authors: Jayadevappa R, Malkowicz SB, Chhatre S, Johnson JC, Gallo JJ

• HIV infection and glycemic response to newly initiated diabetic medical therapy.
  AIDS (London, England). 2012 Oct 23;26(16):2087-95; Authors: Han JH, Crane HM, Bellamy SL, Frank I, Cardillo S, Bisson GP, Centers for AIDS Research Network of Integrated Clinical Systems (CNICS)

• Comparison of distribution- and anchor-based approaches to infer changes in health-related quality of life of prostate cancer survivors.
  Health services research. 2012 Oct;47(5):1902-25 Epub 2012 Mar 14; Authors: Jayadevappa R, Malkowicz SB, Wittink M, Wein AJ, Chhatre S

• Early data from Project Engage: a program to identify and transition medically hospitalized patients into addictions treatment.
  Addiction science & clinical practice. 2012 Sep 25;7(1):20; Authors: Pecoraro A, Horton T, Ewen E, Becher J, Wright PA, Silverman B, McGraw P, Woody GE

• Vitamin D Levels, Natural H1N1 Infection and Response to H1N1 Vaccine among HIV-Infected Individuals.
  Journal of AIDS & clinical research. 2012 May 20;3(4):152; Authors: Momplaisir F, Frank I, Meyer W 3rd, Kim D, Kappes R, Tebas P

• Pain and physical and psychological symptoms in ambulatory HIV patients in the current treatment era.
  Journal of pain and symptom management. 2012 Mar;43(3):638-45 Epub 2011 Nov 23; Authors: Merlin JS, Cen L, Praestgaard A, Turner M, Obando A, Alpert C, Woolston S, Casarett D, Kostman J, Gross R, Frank I

• Impact of transitioning from HIV clinical trials to routine medical care on clinical outcomes and patient perceptions.
  AIDS care. 2012;24(6):769-77 Epub 2011 Nov 22; Authors: Yehia BR, Long JA, Stearns CR, French B, Tebas P, Frank I

• Using psychiatric symptomatology to assess risk for HIV infection in individuals with severe mental illness.
  Community mental health journal. 2011 Dec;47(6):672-8 Epub 2011 Apr 9; Authors: Wu ES, Rothbard A, Blank MB

• A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness.
  Psychiatric services (Washington, D.C.). 2011 Nov;62(11):1318-24; Authors: Blank MB, Hanrahan NP, Fishbein M, Wu ES, Tennille JA, Ten Have TR, Kutney-Lee AM, Gross R, Hines JM, Coyne JC, Aiken LH

• Topographical continuity of bacterial populations in the healthy human respiratory tract.
  American journal of respiratory and critical care medicine. 2011 Oct 15;184(8):957-63 Epub 2011 Jun 16; Authors: Charlson ES, Bittinger K, Haas AR, Fitzgerald AS, Frank I, Yadav A, Bushman FD, Collman RG

• Battling AIDS in America: an evaluation of the National HIV/AIDS Strategy.
  American journal of public health. 2011 Sep;101(9):e4-8 Epub 2011 Jul 21; Authors: Yehia B, Frank I

• Selectively willing and conditionally able: HIV vaccine trial participation among women at "high risk" of HIV infection.
  Vaccine. 2011 Aug 18;29(36):6130-5 Epub 2011 Jun 23; Authors: Voytek CD, Jones KT, Metzger DS

• Racial differences in well-being and cancer concerns in prostate cancer patients.
  Journal of cancer survivorship : research and practice. 2011 Jun;5(2):182-90 Epub 2011 Jan 28; Authors: Chhatre S, Wein AJ, Malkowicz SB, Jayadevappa R

• Variation in quality of care among older men with localized prostate cancer.
  Cancer. 2011 Jun 1;117(11):2520-9 Epub 2010 Dec 14; Authors: Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB

• Association between ethnicity and prostate cancer outcomes across hospital and surgeon volume groups.
  Health policy (Amsterdam, Netherlands). 2011 Feb;99(2):97-106 Epub 2010 Aug 13; Authors: Jayadevappa R, Chhatre S, Johnson JC, Malkowicz SB

• Randomized Clinical Trial of the Effectiveness of a Home-Based Advanced Practice Psychiatric Nurse Intervention: Outcomes for Individuals with Serious Mental Illness and HIV.
  Nursing research and practice. 2011;2011:840248 Epub 2011 May 17; Authors: Hanrahan NP, Wu E, Kelly D, Aiken LH, Blank MB

• A randomized trial of extended telephone-based continuing care for alcohol dependence: within-treatment substance use outcomes.
  Journal of consulting and clinical psychology. 2010 Dec;78(6):912-23; Authors: McKay JR, Van Horn DH, Oslin DW, Lynch KG, Ivey M, Ward K, Drapkin ML, Becher JR, Coviello DM

• Drug treatment as HIV prevention: a research update.
  Journal of acquired immune deficiency syndromes (1999). 2010 Dec;55 Suppl 1(Suppl 1):S32-6; Authors: Metzger DS, Woody GE, O'Brien CP

• Drug treatment as HIV prevention: expanding treatment options.
  Current HIV/AIDS reports. 2010 Nov;7(4):220-5; Authors: Metzger DS, Zhang Y

• Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.
  Journal of immunology (Baltimore, Md. : 1950). 2010 Nov 1;185(9):5169-79 Epub 2010 Oct 1; Authors: Gordon SN, Cervasi B, Odorizzi P, Silverman R, Aberra F, Ginsberg G, Estes JD, Paiardini M, Frank I, Silvestri G

• Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication.
  Psychosomatic medicine. 2010 Nov;72(9):925-32 Epub 2010 Oct 14; Authors: Benton T, Lynch K, Dubé B, Gettes DR, Tustin NB, Ping Lai J, Metzger DS, Blume J, Douglas SD, Evans DL

• Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals.
  AIDS (London, England). 2010 Sep 10;24(14):2187-92; Authors: Tebas P, Frank I, Lewis M, Quinn J, Zifchak L, Thomas A, Kenney T, Kappes R, Wagner W, Maffei K, Sullivan K, Center for AIDS Research and Clinical Trials Unit of the University of Pennsylvania

• Racial and ethnic variation in health resource use and cost for prostate cancer.
  BJU international. 2010 Sep;106(6):801-8 Epub 2010 Feb 11; Authors: Jayadevappa R, Malkowicz SB, Chhatre S, Gallo J, Schwartz JS

• The burden of out-of-pocket and indirect costs of prostate cancer.
  The Prostate. 2010 Aug;70(11):1255-64; Authors: Jayadevappa R, Schwartz JS, Chhatre S, Gallo JJ, Wein AJ, Malkowicz SB

• Diagnosis and treatment of depression and anxiety in rural and nonrural primary care: national survey results.
  Psychiatric services (Washington, D.C.). 2010 Jun;61(6):624-7; Authors: Jameson JP, Blank MB

• Assessment of cost and health resource utilization for elderly patients with heart failure and diabetes mellitus.
  Journal of cardiac failure. 2010 Jun;16(6):454-60 Epub 2010 Mar 6; Authors: Bogner HR, Miller SD, de Vries HF, Chhatre S, Jayadevappa R

• Association between utility and treatment among patients with prostate cancer.
  Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2010 Jun;19(5):711-20 Epub 2010 Mar 5; Authors: Jayadevappa R, Schwartz JS, Chhatre S, Wein AJ, Malkowicz SB

• Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control.
  PLoS pathogens. 2010 May 27;6(5):e1000917; Authors: Hersperger AR, Pereyra F, Nason M, Demers K, Sheth P, Shin LY, Kovacs CM, Rodriguez B, Sieg SF, Teixeira-Johnson L, Gudonis D, Goepfert PA, Lederman MM, Frank I, Makedonas G, Kaul R, Walker BD, Betts MR

• Satisfaction with care: a measure of quality of care in prostate cancer patients.
  Medical decision making : an international journal of the Society for Medical Decision Making. 2010 Mar-Apr;30(2):234-45 Epub 2009 Aug 12; Authors: Jayadevappa R, Schwartz JS, Chhatre S, Wein AJ, Malkowicz SB

• Empirically supported treatments in rural community mental health centers: a preliminary report on current utilization and attitudes toward adoption.
  Community mental health journal. 2009 Dec;45(6):463-7; Authors: Jameson JP, Chambless DL, Blank MB

• Cost of treating seriously mentally ill persons with HIV following highly active retroviral therapy (HAART).
  The journal of mental health policy and economics. 2009 Dec;12(4):187-94; Authors: Rothbard AB, Lee S, Blank MB

• Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer.
  The Prostate. 2009 Jul 1;69(10):1067-76; Authors: Jayadevappa R, Chhatre S, Wein AJ, Malkowicz SB

• If we build it, they might come: an empirical investigation of supply and demand in the recruitment of rural psychologists.
  Journal of clinical psychology. 2009 Jul;65(7):723-35; Authors: Jameson JP, Blank MB, Chambless DL

• Incremental burden of congestive heart failure among elderly with Alzheimer's.
  Aging & mental health. 2009 Jul;13(4):628-34; Authors: Chhatre S, Weiner MG, Jayadevappa R, Johnson JC

• Previously undetected metabolic syndromes and infectious diseases among psychiatric inpatients.
  Psychiatric services (Washington, D.C.). 2009 Apr;60(4):534-7; Authors: Rothbard AB, Blank MB, Staab JP, TenHave T, Young DS, Berry SD, Eachus S

• A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients.
  Virology. 2008 Sep 15;379(1):78-86 Epub 2008 Jul 22; Authors: Yu JJ, Wu TL, Liszewski MK, Dai J, Swiggard WJ, Baytop C, Frank I, Levine BL, Yang W, Theodosopoulos T, O'Doherty U

• Incidence of transaminitis among HIV-infected patients with occult hepatitis B.
  Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 2008 Sep;43(1):32-6 Epub 2008 May 16; Authors: Lo Re V 3rd, Wertheimer B, Localio AR, Kostman JR, Dockter J, Linnen JM, Giachetti C, Dorey-Stein Z, Frank I, Strom BL, Gross R

• Antiretroviral failure despite high levels of adherence: discordant adherence-response relationship in Botswana.
  Journal of acquired immune deficiency syndromes (1999). 2008 Sep 1;49(1):107-10; Authors: Bisson GP, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R

• Gastro-oesophageal acid-related disease, co-morbidity and medical care cost.
  Chronic illness. 2008 Sep;4(3):209-18; Authors: Jayadevappa R, Chhatre S, Weiner M

• Sexually transmitted infection among adolescents receiving special education services.
  The Journal of school health. 2008 Jul;78(7):382-8; Authors: Mandell DS, Eleey CC, Cederbaum JA, Noll E, Hutchinson MK, Jemmott LS, Blank MB

• Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.
  PLoS medicine. 2008 May 20;5(5):e109; Authors: Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB

• Validation and toxicity of PI3K/Akt pathway inhibition by HIV protease inhibitors in humans.
  Cancer biology & therapy. 2008 May;7(5):628-35 Epub 2008 May 14; Authors: Plastaras JP, Vapiwala N, Ahmed MS, Gudonis D, Cerniglia GJ, Feldman MD, Frank I, Gupta AK

• CD127 and CD25 expression defines CD4+ T cell subsets that are differentially depleted during HIV infection.
  Journal of immunology (Baltimore, Md. : 1950). 2008 Apr 15;180(8):5582-92; Authors: Dunham RM, Cervasi B, Brenchley JM, Albrecht H, Weintrob A, Sumpter B, Engram J, Gordon S, Klatt NR, Frank I, Sodora DL, Douek DC, Paiardini M, Silvestri G

• Overestimates of survival after HAART: implications for global scale-up efforts.
  PloS one. 2008 Mar 5;3(3):e1725; Authors: Bisson GP, Gaolathe T, Gross R, Rollins C, Bellamy S, Mogorosi M, Avalos A, Friedman H, Dickinson D, Frank I, Ndwapi N

• The first national scientific meeting of the Social and Behavioral Science Research Network.
  Journal of acquired immune deficiency syndromes (1999). 2008 Mar 1;47 Suppl 1:S1-4; Authors: Blank MB, Metzger DS, Wingood GM, DiClemente RJ

• Examining racial disparities in HIV: lessons from sexually transmitted infections research.
  Journal of acquired immune deficiency syndromes (1999). 2008 Mar 1;47 Suppl 1:S20-7; Authors: Kraut-Becher J, Eisenberg M, Voytek C, Brown T, Metzger DS, Aral S

• Mucosal immune dysfunction in AIDS pathogenesis.
  AIDS reviews. 2008 Jan-Mar;10(1):36-46; Authors: Paiardini M, Frank I, Pandrea I, Apetrei C, Silvestri G

• Childhood sexual and physical abuse histories, PTSD, depression, and HIV risk outcomes in women injection drug users: a potential mediating pathway.
  The American journal on addictions. 2007 Nov-Dec;16(6):431-8; Authors: Plotzker RE, Metzger DS, Holmes WC

• Steady-state pharmacokinetics of once-daily fosamprenavir/ritonavir and atazanavir/ritonavir alone and in combination with 20 mg omeprazole in healthy volunteers.
  HIV medicine. 2007 Oct;8(7):457-64; Authors: Luber AD, Brower R, Kim D, Silverman R, Peloquin CA, Frank I

• The locus for bovine dilated cardiomyopathy maps to chromosome 18.
  Animal genetics. 2007 Jun;38(3):265-9 Epub 2007 Apr 13; Authors: Guziewicz KE, Owczarek-Lipska M, Küffer J, Schelling C, Tontis A, Denis C, Eggen A, Leeb T, Dolf G, Braunschweig MH

• Ethnic variation in return to baseline values of patient-reported outcomes in older prostate cancer patients.
  Cancer. 2007 Jun 1;109(11):2229-38; Authors: Jayadevappa R, Johnson JC, Chhatre S, Wein AJ, Malkowicz SB

• Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.
  Journal of acquired immune deficiency syndromes (1999). 2007 Mar 1;44(3):315-20; Authors: Lo Re V 3rd, Frank I, Gross R, Dockter J, Linnen JM, Giachetti C, Tebas P, Stern J, Synnestvedt M, Localio AR, Kostman JR, Strom BL

• Incidence and risk factors for weight loss during dual HIV/hepatitis C virus therapy.
  Journal of acquired immune deficiency syndromes (1999). 2007 Mar 1;44(3):344-50; Authors: Lo Re V 3rd, Kostman JR, Gross R, Reddy KR, Mounzer K, Zemel BS, Rennert H, Stieritz DD, Putt M, Frank I, Strom BL

• Self-reported hepatitis B and C virus infections had low sensitivity among HIV-infected patients.
  Journal of clinical epidemiology. 2007 Mar;60(3):294-9 Epub 2006 Nov 13; Authors: Lo Re V 3rd, Frank I, Gross R, Synnestvedt M, Localio AR, Kostman JR, Strom BL

• Appropriateness of antiretroviral therapy in clients of an HIV/AIDS case management organization.
  AIDS care. 2007 Feb;19(2):273-81; Authors: Holmes WC, Pace JL, Frank I

• HIV and mental illness: opportunities for prevention.
  Journal of prevention & intervention in the community. 2007;33(1-2):1-4; Authors: Blank MB, Eisenberg MM

• Effectiveness of transcendental meditation on functional capacity and quality of life of African Americans with congestive heart failure: a randomized control study.
  Ethnicity & disease. 2007 Winter;17(1):72-7; Authors: Jayadevappa R, Johnson JC, Bloom BS, Nidich S, Desai S, Chhatre S, Raziano DB, Schneider R

• Rapid assessment of existing HIV prevention programming in a community mental health center.
  Journal of prevention & intervention in the community. 2007;33(1-2):137-51; Authors: Solomon PL, Tennille JA, Lipsitt D, Plumb E, Metzger D, Blank MB

• Perceived facilitators and barriers to the implementation of an advanced practice: nursing intervention for HIV regimen adherence among the seriously mentally ill.
  Journal of psychiatric and mental health nursing. 2006 Oct;13(5):626-8; Authors: Lee AK, Hanrahan NP, Aiken LH, Blank MB

• Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy.
  AIDS (London, England). 2006 Aug 1;20(12):1613-9; Authors: Bisson GP, Gross R, Strom JB, Rollins C, Bellamy S, Weinstein R, Friedman H, Dickinson D, Frank I, Strom BL, Gaolathe T, Ndwapi N

• Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector.
  AIDS (London, England). 2006 Jun 12;20(9):1333-6; Authors: Bisson GP, Frank I, Gross R, Lo Re V 3rd, Strom JB, Wang X, Mogorosi M, Gaolathe T, Ndwapi N, Friedman H, Strom BL, Dickinson D

• Health-related quality of life and satisfaction with care among older men treated for prostate cancer with either radical prostatectomy or external beam radiation therapy.
  BJU international. 2006 May;97(5):955-62; Authors: Jayadevappa R, Chhatre S, Whittington R, Bloom BS, Wein AJ, Malkowicz SB

• Health resource utilization and medical care cost of acute care elderly unit patients.
  Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research. 2006 May-Jun;9(3):186-92; Authors: Jayadevappa R, Chhatre S, Weiner M, Raziano DB

• Effect of GB virus C viremia on HIV acquisition and HIV set-point.
  AIDS (London, England). 2005 Nov 4;19(16):1910-2; Authors: Bisson GP, Strom BL, Gross R, Weissman D, Klinzman D, Hwang WT, Kostman JR, Metzger D, Stapleton JT, Frank I

• Morphine withdrawal enhances hepatitis C virus replicon expression.
  The American journal of pathology. 2005 Nov;167(5):1333-40; Authors: Wang CQ, Li Y, Douglas SD, Wang X, Metzger DS, Zhang T, Ho WZ

• A tale of 2 epidemics: the intersection between obesity and HIV infection in Philadelphia.
  Journal of acquired immune deficiency syndromes (1999). 2005 Aug 15;39(5):557-61; Authors: Amorosa V, Synnestvedt M, Gross R, Friedman H, MacGregor RR, Gudonis D, Frank I, Tebas P

• Medical care cost of patients with prostate cancer.
  Urologic oncology. 2005 May-Jun;23(3):155-62; Authors: Jayadevappa R, Chhatre S, Weiner M, Bloom BS, Malkowicz SB

• Trends in diagnosis rates for autism and ADHD at hospital discharge in the context of other psychiatric diagnoses.
  Psychiatric services (Washington, D.C.). 2005 Jan;56(1):56-62; Authors: Mandell DS, Thompson WW, Weintraub ES, Destefano F, Blank MB

• Antiretroviral rounds. When to rock the boat?
  AIDS clinical care. 2004 Nov;16(11):90, 94; Authors: Frank I, Shulman N

• Cost effects of a specialized care center for people with Alzheimer's disease.
  American journal of Alzheimer's disease and other dementias. 2004 Jul-Aug;19(4):226-32; Authors: Bloom BS, Chhatre S, Jayadevappa R

• HIV-related lipodystrophy and related factors.
  Atherosclerosis. 2004 May;174(1):1-10; Authors: Tershakovec AM, Frank I, Rader D

• Breast cancer treatment in clinical practice compared to best evidence and practice guidelines.
  British journal of cancer. 2004 Jan 12;90(1):26-30; Authors: Bloom BS, de Pouvourville N, Chhatre S, Jayadevappa R, Weinberg D

• Human immunodeficiency virus prevention and the potential of drug abuse treatment.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2003 Dec 15;37 Suppl 5:S451-6; Authors: Metzger DS, Navaline H

• HIV prevention among injection drug users: the need for integrated models.
  Journal of urban health : bulletin of the New York Academy of Medicine. 2003 Dec;80(4 Suppl 3):iii59-66; Authors: Metzger DS, Navaline H

• Cost of care for Medicaid recipients with serious mental illness and HIV infection or AIDS.
  Psychiatric services (Washington, D.C.). 2003 Sep;54(9):1240-6; Authors: Rothbard AB, Metraux S, Blank MB

• An unusual syncytia-inducing human immunodeficiency virus type 1 primary isolate from the central nervous system that is restricted to CXCR4, replicates efficiently in macrophages, and induces neuronal apoptosis.
  Journal of neurovirology. 2003 Aug;9(4):432-41; Authors: Yi Y, Chen W, Frank I, Cutilli J, Singh A, Starr-Spires L, Sulcove J, Kolson DL, Collman RG

• Alcohol potentiates hepatitis C virus replicon expression.
  Hepatology (Baltimore, Md.). 2003 Jul;38(1):57-65; Authors: Zhang T, Li Y, Lai JP, Douglas SD, Metzger DS, O'Brien CP, Ho WZ

• Sociodemographic and behavioral characteristics associated with timeliness and retention in a 6-month follow-up study of high-risk injection drug users.
  American journal of epidemiology. 2003 May 15;157(10):930-9; Authors: Messiah A, Navaline H, Davis-Vogel A, Tobin-Fiore D, Metzger D

• Alternative mental health services: the role of the black church in the South.
  American journal of public health. 2002 Oct;92(10):1668-72; Authors: Blank MB, Mahmood M, Fox JC, Guterbock T

• Development of a human neuronal cell model for human immunodeficiency virus (HIV)-infected macrophage-induced neurotoxicity: apoptosis induced by HIV type 1 primary isolates and evidence for involvement of the Bcl-2/Bcl-xL-sensitive intrinsic apoptosis pathway.
  Journal of virology. 2002 Sep;76(18):9407-19; Authors: Chen W, Sulcove J, Frank I, Jaffer S, Ozdener H, Kolson DL

• Once-daily HAART: toward a new treatment paradigm.
  Journal of acquired immune deficiency syndromes (1999). 2002 Sep 1;31 Suppl 1:S10-5; discussion S24-5; Authors: Frank I

• Antivirals against HIV-1.
  Clinics in laboratory medicine. 2002 Sep;22(3):741-57, vii; Authors: Frank I

• Co-occurrence of HIV and serious mental illness among Medicaid recipients.
  Psychiatric services (Washington, D.C.). 2002 Jul;53(7):868-73; Authors: Blank MB, Mandell DS, Aiken L, Hadley TR

• Who will enroll? Predicting participation in a phase II AIDS vaccine trial.
  Journal of acquired immune deficiency syndromes (1999). 2001 Jul 1;27(3):281-8; Authors: Halpern SD, Metzger DS, Berlin JA, Ubel PA

• Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro.
  AIDS research and human retroviruses. 2000 Oct 10;16(15):1527-37; Authors: Albright AV, Erickson-Viitanen S, O'Connor M, Frank I, Rayner MM, González-Scarano F

• Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol Team.
  American journal of epidemiology. 2000 Jul 15;152(2):99-106; Authors: Metzger DS, Koblin B, Turner C, Navaline H, Valenti F, Holte S, Gross M, Sheon A, Miller H, Cooley P, Seage GR 3rd

• Clinical use of hydroxyurea in HIV-1 infected patients.
  Journal of biological regulators and homeostatic agents. 1999 Jul-Sep;13(3):186-91; Authors: Frank I

• Drug abuse treatment as AIDS prevention.
  Public health reports (Washington, D.C. : 1974). 1998 Jun;113 Suppl 1(Suppl 1):97-106; Authors: Metzger DS, Navaline H, Woody GE

• Biochemical changes in the frontal lobe of HIV-infected individuals detected by magnetic resonance spectroscopy.
  Proceedings of the National Academy of Sciences of the United States of America. 1997 Sep 2;94(18):9854-9; Authors: López-Villegas D, Lenkinski RE, Frank I

• Frequency and cytokine profile of HPRT mutant T cells in HIV-infected and healthy donors: implications for T cell proliferation in HIV disease.
  The Journal of clinical investigation. 1997 Feb 15;99(4):663-8; Authors: Paganin C, Monos DS, Marshall JD, Frank I, Trinchieri G

• Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
  Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association. 1995 Dec 15;10(5):577-85; Authors: Meyers K, Metzger DS, McLellan AT, Navaline H, Sheon AR, Woody GE

• Failure of culture and polymerase chain reaction to detect human immunodeficiency virus (HIV) in seronegative steady sexual partners of HIV-infected individuals.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1995 Jul;21(1):122-7; Authors: MacGregor RR, Dubin G, Frank I, Hodinka RL, Friedman HM

• Focal networks and HIV risk among African-American male intravenous drug users.
  NIDA research monograph. 1995;151:89-108; Authors: Frey FW, Abrutyn E, Metzger DS, Woody GE, O'Brien CP, Trusiani P

• Tuberculin reactions among attendees at a methadone clinic: relation to infection with the human immunodeficiency virus.
  Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1994 Dec;19(6):1100-4; Authors: MacGregor RR, Dunbar D, Graziani AL

• Proton MR spectroscopy of brain abnormalities in neonates born to HIV-positive mothers.
  AJNR. American journal of neuroradiology. 1994 Nov;15(10):1853-9; Authors: Cortey A, Jarvik JG, Lenkinski RE, Grossman RI, Frank I, Delivoria-Papadopoulos M

• Parental relationships and substance use among methadone patients. The impact on levels of psychological symptomatology.
  Journal of substance abuse treatment. 1994 Sep-Oct;11(5):415-23; Authors: Rutherford MJ, Metzger DS, Alterman AI

• Epidemiology and clinical manifestations of human immunodeficiency virus infection.
  Seminars in roentgenology. 1994 Jul;29(3):230-41; Authors: Frank I, Fishman N

• HIV vaccine trials: will intravenous drug users enroll?
  American journal of public health. 1994 May;84(5):761-6; Authors: Meyers K, Metzger DS, Navaline H, Woody GE, McLellan AT

• Pulmonary aspergillosis in patients with AIDS. Clinical and radiographic correlations.
  Chest. 1994 Jan;105(1):37-44; Authors: Miller WT Jr, Sais GJ, Frank I, Gefter WB, Aronchick JM, Miller WT

• Nurse practitioner managed care for persons with HIV infection.
  Image--the journal of nursing scholarship. 1993 Fall;25(3):172-7; Authors: Aiken LH, Lake ET, Semaan S, Lehman HP, O'Hare PA, Cole CS, Dunbar D, Frank I

• Human immunodeficiency virus seroconversion among intravenous drug users in- and out-of-treatment: an 18-month prospective follow-up.
  Journal of acquired immune deficiency syndromes. 1993 Sep;6(9):1049-56; Authors: Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, DePhilippis D, Stolley P, Abrutyn E

• Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation.
  Radiology. 1993 Mar;186(3):739-44; Authors: Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I

• Attitudes toward mandatory human immunodeficiency virus testing and contact tracing. A survey of intravenous drug users in treatment.
  Journal of substance abuse treatment. 1992;9(1):39-42; Authors: DePhilippis D, Metzger DS, Woody GE, Navaline HA

• Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity.
  Journal of virology. 1991 Dec;65(12):7046-50; Authors: Dubin G, Socolof E, Frank I, Friedman HM

• Glycoprotein C of herpes simplex virus type 1 prevents complement-mediated cell lysis and virus neutralization.
  The Journal of infectious diseases. 1990 Aug;162(2):331-7; Authors: Harris SL, Frank I, Yee A, Cohen GH, Eisenberg RJ, Friedman HM

• Herpes simplex virus type 1 encodes two Fc receptors which have different binding characteristics for monomeric immunoglobulin G (IgG) and IgG complexes.
  Journal of virology. 1990 Jun;64(6):2725-31; Authors: Dubin G, Frank I, Friedman HM

• Decisions in P. carinii pneumonia.
  Hospital practice (Office ed.). 1990 Apr 30;25(4A):8, 13-4; Authors: Frank I, MacGregor RR

• Psychiatric symptoms, high risk behaviors and HIV positivity among methadone patients.
  NIDA research monograph. 1990;105:490-1; Authors: Metzger DS, Woody GE, Druley P, DePhillips D, Navaline H, McLellan AT, O'Brien CP

• Long-term outpatient treatment of CMV retinitis with ganciclovir in AIDS patients.
  The British journal of ophthalmology. 1989 Dec;73(12):996-1001; Authors: Weisenthal RW, Sinclair SH, Frank I, Rubin DH

• A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G.
  Journal of virology. 1989 Nov;63(11):4479-88; Authors: Frank I, Friedman HM

• Psychiatric symptoms in HIV test consenters and refusers.
  NIDA research monograph. 1989;95:415-6; Authors: Woody G, Metzger DS, McLellan AT, O'Brien CP, DiPhilipis D

• Naltrexone in federal probationers.
  NIDA research monograph. 1989;95:465-6; Authors: Metzger DS, Cornish J, Woody GE, McLellan AT, Druley P, O'Brien CP

• Progress in the treatment of cytomegalovirus pneumonia.
  Annals of internal medicine. 1988 Nov 15;109(10):769-71; Authors: Frank I, Friedman HM